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Abstract 
 H2A.Z is a variant of the H2A core histone, and is well known to be important for 
transcriptional regulation in eukaryotic cells. It was recently discovered that higher 
eukaryotes have two almost identical isoforms of H2A.Z that differ only by 3 amino 
acids. Although current biochemical studies are unable to distinguish between the 
native H2A.Z isoforms, several studies have shown potential non-redundant functions 
between the two. For my thesis work, CRISPR-Cas9 was used to insert a small epitope 
tag to the C-terminus region of either H2A.Z1 and H2A.Z2 in 293T cells to allow us to 
study the two isoforms individually in their native states. We successfully generated 3 
H2A.Z1-Strep and 3 H2A.Z2-Strep clones, and confirmed that there were minimal off-
target effects by Cas9 nuclease. However, the H2A.Z1-Strep clones were found to have 
much lower than normal H2A.Z1 expression whereas H2A.Z2-Strep clones have normal 
levels of H2A.Z expression. Strep-tag ChIP data showed H2A.Z1 being enriched on the 
proximal region of the transcription start site (TSS) of the MTA1 gene compared to 
H2A.Z2. For a second project, an Avi-tag BirA system was used to test for SUMOylation 
of H2A.Z in mammalian cells. This method was also used to determine whether there 
are proteins in proximity to H2A.Z that can be SUMOylated. Our assay did not detect 
any H2A.Z SUMOylation; however, there were a few proteins within close proximity to 
H2A.Z that appeared to be SUMOylated. These putative SUMOylated proteins (which 
are biotinylated by the fusion H2A.Z-BirA) were purified by Streptavidin-coupled beads 
and awaiting identification by mass spectrometry.  
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Chapter 1: General Introduction 
1.1 DNA compaction in nucleus and its role in transcription regulation 
 The human genome is made up of approximately 6 billion base-pairs (bp) of 
DNA, which translates to roughly 2 meters in length. It is compacted into a nucleus that 
is typically 5-10 um in diameter (Nelson & Cox, 2008). In the eukaryotic nucleus, DNA is 
wrapped around histone proteins to form nucleosomes, which are the basic repeating 
units of chromatin. Each nucleosome comprises of about 147 bp of DNA wrapped 
around an octamer that contains 2 copies each of the 4 core histones, H2A, H2B, H3, 
and H4 (Richmond et al, 1984). This forms the first structural level of DNA organization. 
Nucleosomes are connected to one another by linker DNA, and some nucleosomes 
may also contain the linker histone, H1, that binds and locks in place the linker DNA 
regions that enter and exit the nucleosome structure (Olins and Olins, 1974; Luger et al, 
1997; Carruthers et al, 1990). This forms a higher structural level of DNA organization. 
Despite the need to compact DNA in the nucleus, DNA also has to be accessible to 
DNA binding factors at the right time and regions. The eukaryotic genome can be 
organized into euchromatin, which are regions where the chromatin is less compact, or 
heterochromatin, which are regions containing more compact chromatin (Campos and 
Reinberg, 2009). Heterochromatin is further classed into constitutive heterochromatin, 
where it is always highly condensed, or facultative heterochromatin, where chromatin 
compaction can vary at different times during differentiation. Packing of the genome into 
different chromatin states allows for the control of DNA accessibility to nuclear proteins 
involved in different genome-mediated processes such as transcription. Therefore, 
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regulating chromatin compaction and nucleosomal positioning are important factors that 
contribute to the proper control of gene expression. 
 The importance of chromatin in transcription was elucidated when it was 
discovered that nucleosomes impeded transcription in vitro (Knezetic and Luse, 1986; 
Lorch et al, 1987) and that gene expression was affected in a specific manner when the 
histones or their basic tails were deleted (Han and Grunstein, 1988; Kayne et al, 1988). 
Additionally, the role of chromatin in transcription was further supported by the 
identifications of the first transcription-linked histone acetyltransferase (Brownell et al, 
1996) and transcription-related chromatin-remodeling complexes (Cote et al, 1994). 
Accumulated evidence suggests that chromatin structure also impacts on other DNA-
related metabolic processes besides transcription, such as recombination, DNA 
damage and repair, and replication. However, this thesis focuses on transcription, and 
more importantly, on epigenetic regulation of transcription. More specifically, my work 
focuses on post-transcription modifications of histones and the functions of the histone 
variant, H2A.Z.  
 
1.2 Histone variants and its role in transcription regulation 
1.2.1 Histones variants in chromatin structure and transcription  
 Chromatin structure can be modulated by ATP-dependent chromatin remodeling 
complexes as well as by replacement of core histones within the nucleosome context by 
histone variants of its own class (Cheung and Lau, 2005). Histone variants provide 
additional levels of chromatin organization since they can interact with variant-specific 
proteins or impart distinct structural and functional properties to the nucleosomes.  
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Deposition of histone variants are mediated by distinct chaperones and mechanisms, 
and represent additional levels of regulation by the cell (Szenker, Ray-Gallet, & 
Almouzni, 2011; Talbert & Henikoff, 2010). Histone variants are encoded by separate 
genes distinct from their core counterparts. Outside of the amino acid sequences that 
are conserved between the core and histone variants, each variant also has stretches of 
unique amino acid sequences that confer specific properties and functions. The core 
histones are replication dependent as they are mostly expressed in S phase and their 
incorporation into chromatin is connected to synthesis of DNA. This ensures that there 
are sufficient core histones for incorporation into nucleosomes at newly replicated DNA 
strands, and allow for efficient chromatin packaging. The 4 core histones are each 
encoded by multi-copy genes and their transcripts lack introns and poly A tails (Marzluff, 
Wagner, & Duronio, 2008). In contrast, transcription of histone variant genes is not 
restricted to S phase and is not dependent on replication of DNA (Wu and Bonner, 
1981).  Histone variants are encoded by single-copy genes and their transcripts contain 
both introns and poly A tails. When core histones are replaced by histone variants of its 
own class within the nucleosome, the biochemical properties of the nucleosome are 
modified. Therefore, histone variants add another layer of complexity as it can change 
the combinations of potential post-translational modifications (PTMs) of the histones 
within the nucleosomes, and can alter interactions of the nucleosome with other 
proteins or DNA, and/or change the structure of the chromatin (Talbert & Henikoff, 
2010). Nucleosomes that contain two copies of the same histone are homotypic while 
nucleosomes that contain a core histone and a variant histone or two different variants 
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are called heterotypic. The existence of both homotypic and heterotypic nucleosome 
supports the ‘nucleosome code’ hypothesis (Bernstein & Hake, 2006), which explains 
increased flexibility in nucleosome formation, stability and structure.   
 
1.2.2 H2A.Z histone variant and its positioning in the genome for gene expression 
regulation 
 In eukaryotes, there are different variants of H2A core histone, of which H2A.X, 
H2A.Bbd, macroH2A, and H2A.Z are the most widely studied. H2A.Z histone variant 
shares 60% homology in the amino acid sequences with its core counterpart H2A 
(Zlatanova and Thakar, 2008). It is also one of the more conserved histone variants, 
with approximately 80% similarity across different species (Lowell et al, 2005). Taken 
together, it implies that H2A.Z has non-redundant roles that other H2A variants are 
unable to compensate for. H2A.Z is deposited by the SWR-1 ATPase complex to 
replace the H2A within the nucleosome (Kobor et al, 2004). The structure and function 
of H2A.Z are evolutionarily conserved as phenotypes associated with the disruption of 
the H2A.Z-coding gene in yeast can be rescued by introduction of the H2A.Z gene from 
the ciliate protozoan Tetrahymena (Jackson and Gorozky, 2000). H2A.Z also has an 
essential role in eukaryotic cells since loss of H2A.Z in more complex organisms, such 
as Tetrahymena thermophile, Drosophila melanogaster, Xenopus laevis, and mice, all 
resulted in lethality (Liu et al, 1996; Clarkson et al, 1999; Faast et al, 2001). On the 
other hand, H2A.Z is not essential in less complex eukaryotes, such as Saccharomyces 
cerevisiae, since H2A.Z-null mutant yeast strains were viable but had defects in 
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transcriptional activation of inducible genes (Santisteban et al, 2000; Adam et al, 2001). 
Knock-out of H2A.Z in Schizosaccharomyces pombe also led to phenotypes indicating 
severe growth defects (Carr et al, 1994). Additionally, H2A.Z was found to be involved 
in recruitment of RNAPII in yeast and human cells (Adam et al, 2000; Hardy et al, 
2009). These functional studies suggest that H2A.Z is involved in transcriptional 
initiation. H2A.Z- and H3.3-containing nucleosomes are less stable than homotypic 
nucleosomes, and are localized on nucleosome-free regions (NFR) of active promoters, 
enhancers and insulators (Chen, Wang, & Li, 2014; Jin et al., 2009). Specifically, 
histone variants H2A.Z and H3.3 are known to be involved in transcription regulation 
(Weber & Henikoff, 2014). Analyses of H2A.Z positioning within the yeast and 
mammalian genomes revealed H2A.Z-containing nucleosomes preferentially localized 
to promoter regions of genes and at nucleosomes flanking the nucleosome-free regions 
(NFR) at transcription start sites (Barski et al, 2007; John et al, 2008; Schones et al, 
2008).  This suggests that nucleosomes containing H2A.Z facilitates gene regulation by 
preventing stability of nucleosomes around regulatory regions that could be displaced 
easily by chromatin-binding complexes to both activate and repress gene expression 
(Hu et al., 2013). Chromatin with H2A.Z nucleosomes were also shown to result in 
higher susceptibility to DNA cleavage by nucleases compared to H2A nucleosomes 
(Tolstorukov et al, 2009). This indicated that more DNA was exposed when DNA was 
bound to nucleosomes containing H2A.Z than H2A histones, which may allow easier 
access by transcriptional activating proteins. Enhancers enriched with H2A.Z were 
linked to chromatin accessibility, epigenetic modifications and recruitment of RNA 
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polymerases (Brunelle et al, 2015). Enhancers are important in achieving transcriptional 
activation by recruitment of transcription factors and co-activator complexes to regulate 
target genes. Despite many studies showing a positive role of H2A.Z on transcription, it 
is important to note that there are also studies that showed H2A.Z can also localize to 
heterochromatin and centromeric regions, and are involved in negatively regulating 
gene transcription (Cheung and Draker, 2009). Moreover, there are also studies that 
showed contradictory results in the role of H2A.Z in nucleosome stability (Marque et al, 
2010). H2A.Z was initially found at heterochromatin sites (Rangasamy et al, 2003), and 
proposed to promote higher-order chromatin structure formation. This is dependent on 
the 2 amino acid residues that resulted in an extended acidic patch of H2A.Z (compared 
to core H2A), which also interacts with HP1!, a heterochromatin protein, to contribute or 
maintain constitutive heterochromatin domains (Fan et al, 2002). However, Fan et al 
(2002) also showed that H2A.Z inhibited the formation of higher order chromatin 
structure that stemmed from intermolecular association. This suggests that H2A.Z could 
play a role in constructing special chromatin regions poised for activation of 
transcription. Furthermore, H2A.Z could also localize to promoters of inducible genes to 
poise them for activation, such as those found at constitutive and hormone-induced 
glucocorticoid receptor binding sites (John et al, 2008). An enrichment of H2A.Z was 
also observed at the promoter of the p21 gene regulated by p53 in U2OS osteosarcoma 
cells, particularly at sites where p53 bind (Gevryet al, 2007). These studies suggested 
that the H2A.Z variant play significant roles in transcriptional activation at multiple levels 
of gene expression regulation. Despite some gaps in our full knowledge, the general 
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consensus is that H2A.Z plays highly dynamic roles in transcription regulation 
depending on its localization to different regions of the genome.  
 
1.3 Role of H2A.Z in cancer 
 Epigenetic states can be regulated by histone variants by allowing or preventing 
stabilization of chromatin structure at the nucleosomal level (Bonisch & Hake, 2012). 
Cancer could hence be contributed by the deregulation of histone variants and their 
regulators at the transcription level. H2A.Z has been implicated in promoting cancer by 
increasing epigenetic plasticity in cancer cells, causing them to lose their ability to 
maintain genomic integrity, altering transcriptional regulation of target genes, and 
potentially affecting the cells’ ability to inhibit senescence. The link between H2A.Z and 
cancer was first reported in sporadic colorectal tumors, where its overexpression was 
observed by genome-wide gene expression profiling (Dunican et al, 2002). H2A.Z was 
also found to be overexpressed inn progressive breast cancer, bladder and malignant 
melanoma (Zink & Hake, 2016). H2A.Z was also found to be involved in androgen 
receptor (AR) gene transactivation and prostate carcinoma (PCa) progression. 
Ubiquitin-specific protease (USP10) deubiquitylation of H2A.Z in K120, K121 and K125 
resulted in AR-regulated PSA and KLK3 gene transcriptional activation (Draker et al, 
2011). Additionally, PCa patients undergoing androgen-deprivation therapy generally 
expressed higher levels of H2A.Z over time, which could be indicative of androgen-
independence in primary PCa progression (Dryhurst et al, 2012). These findings 
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suggest that H2A.Z could be exploited as markers of disease progression and as 
response to cancer therapy.  
 
1.4 CRISPR-Cas9 genome editing tool 
 Clustered, regularly interspaced short palindromic repeats (CRISPR)-associated 
(Cas) system is an immune system of Streptococcus pyogenes that utilizes its 
endogenous nuclease guided by foreign RNA to cleave foreign genetic elements 
(Bhaya et al, 2011). It has been adapted and optimized as a powerful genome editing 
technique. The most characterized type of CRISPR system out of the three identified is 
the Type II (Gasiunas et al, 2012) system. It is composed of Cas9 protein and the 
CRISPR RNA (crRNA), whereby crRNA is matured by a trans-activating CRISPR RNA 
(tracrRNA) containing sequence complementary to repeat regions of pre-crRNA. Cas9 
is an RNA-guided DNA endonuclease enzyme that induces DNA cleavage. Two 
domains in Cas9 endonuclease are responsible for its catalytic activity on the target 
DNA strand; 1. RuvC domains cuts the non-complementary strand; 2. HNH domain cuts 
the complementary strand of the DNA. The optimized CRISPR-Cas9 system for 
genome editing has developed a chimeric, single-guide RNA (sgRNA) that fused crRNA 
and tracrRNA together (Jinek et al, 2012) to guide the Cas9 nuclease to its target site 
on the DNA for cleavage. The sgRNA that guides Cas9 to its complementary target on 
the genome has to be immediately trailed by a 5’-NGG PAM sequence, where N is any 
of the four possible nucleotides. Double-stranded break induced by Cas9 endonuclease 
would occur 3 bp upstream of PAM (Jinek et al, 2012). After cleavage, there are two 
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distinct DNA repair pathways that the cell can undergo depending on the cell cycle 
stage: non-homologous end joining (NHEJ) or homology-directed repair (HDR) (Figure 
1-1). NHEJ repairs DNA damage by directly ligating the broken ends without any 
templates, which often results in deletions or random nucleotide insertions. In HDR 
pathway, DNA templates that contain homology to the break ends are used to repair the 
gene with high fidelity. The nature of genome editing differs when different DNA repair 
pathways are taken. NHEJ often leads to gene knockouts whereas HDR would be 
useful for knock-in experiments. 
 
Figure 1-1. Genome editing tools take advantage of endogenous DNA repair 
machineries to induce edits in the genome. After double-stranded break by Cas9 to 
the target sequence upstream of PAM sequence, repair mechanisms follow to prevent 
permanent DNA damage. Depending on the cell cycle, non-homologous end joining 
(NHEJ) or homology-directed repair (HDR) can occur. In NHEJ, the blunt ends are 
directly ligated without any templates, resulting in deletions or random nucleotide 
insertions. In HDR, a template that contains homology to the break ends is provided to 
fix the DNA break to avoid any mutations in the gene. Through this system, gene 
knockout, via NHEJ, or knock-in, via HDR, lines can be created. (adapted from Urnov et 
al, 2010) 
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1.5 Avi-tag BirA system  
 The avi-tag BirA system is based on in vivo biotinylation that takes advantage of 
the E. coli biotin ligase BirA’s ability to recognize and attach biotin to a short 15-amino 
acid peptide, Avi-tag (26) (Figure 1-2). This system is highly specific as there are no 
known endogenous proteins in mammalian cells that contain the 15-amino acid 
recognition sequence. Additionally, biotinylated avi-tagged proteins could be purified 
using Streptavidin beads in pull-down assays. Biotin binds to avidin/streptavidin beads 
with high affinity and so allows for highly stringent washes during purification of 
biotinylated proteins without fear of early elution or loss of the biotinylated proteins.  
 
Figure 1-2. General representation of the Avi-tag BirA biotinylation system used to 
target SUMOylated proteins on the nucleosome free region of the chromatin. BirA 
ligase is fused to H2A.Z incorporated into nucleosomes, and Avi-tag is fused to SUMO-
1. If proteins located at the transcription start site on the NFR are SUMOylated, a 
portion of SUMO and H2A.Z would be from the endogenous pool while others would 
contain the fusion constructs. When both constructs are localized in proximity to each 
other, BirA would recognize a unique sequence on the 15-amino acid Avi-tag and attach 
biotin to the lysine residue on Avi-tag.  
BirA
Avi-tag
B
= nucleosome
= H2A.Z
= SUMO-1
NFR
B = Biotin
Avi-tag
B
Figure is not drawn to scale
= proteins
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Chapter 2: Generation of endogenous H2A.Z1-Strep and H2A.Z2-Strep cell lines 
using CRISPR-Cas9 
2.1 Introduction 
2.1.1 H2A.Z histone variant isoforms, H2A.Z1 and H2A.Z2 
 Our current understanding of the H2A.Z histone variant is complicated by the 
recent discovery that there are two distinct isoforms, H2A.Z1 and H2A.Z2, that are 
encoded by two non-allelic genes H2AFZ and H2AFV respectively. Even though the 
DNA sequences of these two genes are not conserved, the protein amino acid 
sequences of the two isoforms are almost identical except for 3 amino acid differences 
at residues 15, 39, and 128 (Figure 2-1) (Dryhurst et al, 2009). Other highly conserved 
yet functionally distinct histone variants have been described before.  For example, 
despite high similarity in the primary amino acid sequences between the core histone 
H3.1 and the histone variant H3.3 (they differ only by 4 amino acids), the latter’s 
incorporation into nucleosomes significantly changes the stability of the nucleosome (Jin 
et al., 2009). Therefore, minor changes in amino acid sequences can impart distinct 
functional properties to highly conserved histone variants. The H2AFZ and H2AFV 
genes are driven by distinct promoters, raising the possibility that their expressions are 
regulated by distinct mechanisms and pathways. Despite their almost identical amino 
acid sequences, several pieces of evidence suggests H2A.Z1 and H2A.Z2 have non-
redundant functions. Developing mice that have a deletion of the H2A.Z1 alleles were 
found to be embryonically lethal (Faast et al, 2004), suggesting that the presence of the 
intact H2A.Z2 gene is not sufficient to compensate for the loss of H2A.Z1 during 
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embryonic development. Knock-out of the genes coding for either H2A.Z1 or H2A.Z2 in 
chicken DT40 cells resulted in distinct phenotypic characteristics in terms of cell growth 
and expression of genes (Mastuda et al, 2010). For example, cells deficient in H2A.Z2 
proliferated slower than cells lacking H2A.Z1. In melanoma cells, H2A.Z2 isoform was 
found to be overexpressed and required for the expression of genes targeted by the 
E2F transcription factors, whereas H2A.Z1 was not involved in the regulation of those 
target genes (Vardabasso et al, 2015). Knock-down of either H2A.Z1 or H2A.Z2 in the 
melanoma cells also resulted in differential gene transcription profile, supporting the 
differential functional roles of H2A.Z1 and H2A.Z2. Crystallography studies of H2A.Z1- 
and H2A.Z2-containing nucleosomes found distinct structural differences in the L1 loops 
of the respective isoforms, resulting in higher turnover rates of H2A.Z1 compared to 
H2A.Z2 in normal conditions (Horikoshi et al, 2013). In response to DNA damage 
resulting double stranded breaks, the opposite effect was observed where nucleosomal 
H2A.Z2 is more rapidly swapped than H2A.Z1 (Nishibuchi et al, 2014). All together, 
these studies illustrate the differential functions of H2A.Z1 and H2A.Z2 isoforms in 
transcriptional regulation and other nuclear processes.  
 
Figure 2-1. Difference in amino acid sequence between H2A.Z1 and H2A.Z2. While 
most of the amino acid sequences between the two isoforms are identical, there are 
three residues where they differ. At residues 15, 39, and 128, it is threonine, serine, and 
valine in H2A.Z1 while it is alanine, threonine, and alanine in H2A.Z2 respectively.  
Modified from Ausiò et al, 2009
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2.1.2 Research rationale and objective 
 To date, most biochemical studies of H2A.Z do not distinguish between H2A.Z1 
and H2A.Z2 since there are no commercially available antibodies that can distinguish 
between the two isoforms. The three amino acids that differ between the isoforms are 
far apart and do not form a single distinguishable epitope together. Therefore, it is not 
easy to generate isoform-specific antibodies. Functional studies in mammalian cells 
often rely on ectopic expression of epitope-tagged H2A.Z1 and H2A.Z2 proteins to 
distinguish between the two isoforms. One of the main drawbacks of these ectopic 
expression studies is that the transgenes are not expressed from the endogenous 
promoters and therefore, not subjected to the native regulated expression of the 
endogenous genes. Also, differential expression of the H2A.Z isoforms can only be 
determined at the mRNA levels, but not at the protein levels. Therefore, the goal of this 
project is to add the DNA sequence of an epitope tag in frame to the endogenous 
H2A.Z1 or H2A.Z2 coding sequences in order to generate fusion protein that can be 
detected by antibodies against the tag (Figure 2-2). The tagged isoforms would still be 
driven by the respective endogenous promoters and, therefore, allow more 
physiologically relevant studies of the two isoforms. To achieve our goal, we utilized the 
genome editing system, CRISPR-Cas9, to insert a Strep-tag DNA sequence just before 
its stop codon at the 3’ end of the endogenous H2A.Z1 and H2A.Z1 genes. Once 
expressed, H2A.Z1 or H2A.Z2 would have a Strep-tag present at its C-terminus. Strep-
tag, which comprises 8 amino acids and approximately 1 kDa in size, was chosen for its 
small size and molecular weight addition. We hoped that the small tag would hence not 
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occlude or interfere with the functionality of the regions on H2A.Z1 or H2A.Z2. 
Additionally, Strep-tag binds with a strong affinity to Streptactin, which would be useful 
for affinity purification approaches. For example, immunoprecipitation of Strep-tagged 
H2A.Z1 and H2A.Z2 could be conducted and used to identify co-purifying interactors. 
Chromatin immunoprecipitation (ChIP) could also be performed and identify genomic 
regions that differentially associate with the Strep-tagged H2A.Z1 or H2A.Z2 isoforms. 
We decided to generate endogenous H2A.Z1-Strep and H2A.Z2-Strep cell lines in 293T 
cells due to the easy handling and high transfection efficiency of these cells.  
 
 
 
 
Figure 2-2. Objective of using CRISPR-Cas9 genome editing system. Strep tag 
would be inserted right before the Stop codon of H2AFZ and H2AFV without resulting in 
any mutations elsewhere. This would prevent any frameshift mutations as well. Repair 
templates would be present for the cell to undergo homology-directed repair. When the 
genes are expressed, the Strep-tag would be transcribed and translated as well. Stop 
codon is underlined.  
 
 
Exon 1 Exon 2 Exon 3 Exon 4 AAGACTGTC TAAExon 5H2AFZ
Exon 1 Exon 2 Exon 3 Exon 4 AAAACTGCT TAGExon 5H2AFV
DNA sequence
Homology-directed repairTGGAGCCACCCGCAGTTCGAGAAA
Strep-tag
HA HARepair template
Exon 4 AAGACTGTCTGGAGCCACCCGCAGTTCGAGAAATAAExon
Exon 4 AAAACTGCTTGGAGCCACCCGCAGTTCGAGAAATAGExon
Exon 3
Exon 3
Strep-tag
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2.1.3 Designing an optimized CRISPR-Cas9 genome editing process for insertion of 
Strep-tag to H2A.Z histone variant isoforms  
 In the CRISPR-Cas9 system, double strand breaks introduced by the Cas9 
nuclease can either be repaired by the NHEJ or HDR pathways. For this study, given 
the goal is to insert the Strep-tag sequence in frame to the endogenous H2A.Z1 and 
H2A.Z2 coding sequence, the HDR mechanism is needed to perform this task (Figure 
2-3). HDR generally occurs in the late S and G2 phase of the cell cycle, when sister 
chromatids are present to serve as repair templates after DNA replication to fix any 
errors that might have occurred (Heyer et al, 2010). In contrast, NHEJ takes place 
throughout the whole cell cycle and acts as a competitor to HDR for DNA reparation, 
even at S and G2 phase. It also actively inhibits HDR at M phase and early G1 
(Orthwein et al, 2014). Therefore, the overall frequency of HDR occuring in normal 
cycling cells is generally quite low, which explains why inserting DNA sequences into 
the genome by the CRISPR-Cas9 system is known to be difficult and low in efficiency. 
 
 We have attempted to enhance HDR efficiency by using Nocodazole to arrest 
cell cycle at G2/M phase, where HDR is known to be most efficient (Gutschner et al 
2016). Prior optimization experiment using FACS analysis showed that Nocodazole 
treatment at 200 ng/mL for 20 hours synchronized the highest amount of cell population 
at the G2/M phase using FACS analysis and higher amounts of Cas9 protein 
expressed. Additionally, i53 protein was also used to inhibit 53BP1, which is an 
important regulator of DSB repair pathway choice that normally promotes NHEJ by 
preventing end resection to inhibit HDR (Canny et al., 2017). By inhibiting 53BP1 that 
	 16	
promotes NHEJ, others have shown that addition of i53 to the CRISPR-Cas9 system 
can improve the success rate of generating genomic insertions of targeted DNA 
sequences.  
 
 
 
Figure 2-3. Designs of sgRNA and repair templates to genes of H2A.Z1 and 
H2A.Z2; H2AFZ and H2AFV. The respective sgRNA is targeted to the C-terminus of 
the 2 genes, and Cas9 will cleave 3 nucleotides upstream of the unique PAM sequence. 
For H2AFZ, the cut site is 5 nucleotides downstream of the site of insertion. For H2AFV, 
the cut site is exactly at the site of insertion, making it ideal. Repair templates for both 
H2AFZ and H2AFV contain the Strep-tag sequence and 3 linkers upstream, with both 
flanked by symmetric homology arms to their respective genes. The linker nucleotide 
sequence used is GGGAGGGAGGGATCC, which would translate to GGGS. The linker 
sequences were used to distance the H2A.Z1 and H2A.Z2 protein from the Strep-tag. 	
  
H2AFZ
H2AFV
Cas9
Cas9
Target PAM
sgRNA
Target PAM
sgRNA
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2.2 Materials and methods 
2.2.1 CRISPR-Cas9 procedure, and plasmids 
 Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% fetal 
bovine serum (FBS) and 1% penicillin-streptomycin were used to grow 293T cells. They 
were then used when their passage numbers were still low for transfection and 
generation of CRISPR-Cas9 clones with Strep-tag inserted at the C-terminus of H2A.Z1 
and H2A.Z2. The CRISPR-Cas9 expression constructs were based on the PX459 
plasmid (Addgene #62988, Ran et al, 2013) backbone containing the gene sequence 
for the SpCas9 protein and a cloning site for the single guide RNAs (sgRNAs). 
Previously, the unique sgRNA sequence targeting the C-terminus of H2A.Z1 and 
H2A.Z2, as well as a Scrambled sgRNA sequence that is known to not target any sites 
on the human genome have been successfully cloned into PX459 plasmid vector. 
PX459 plasmid containing sgRNA targeting C-terminus of H2A.Z1 and H2A.Z2 would 
be henceforth referred to as H2A.Z1 sgRNA and H2A.Z2 sgRNA respectively. PX459 
plasmid containing the sgRNA for the Scrambled sequence would be referred to 
interchangeably as Scr-sgRNA. Repair template used had 35 base pairs serving as 5’ 
and 3’ homology arms to the C-terminus region of either H2A.Z1 or H2A.Z2 flanking a 
three-linker sequence (GGGSGGGSGGGSA) and strep-tag (WSHPQFEK). All co-
transfections were conducted using PolyJet reagent with either H2A.Z1-sgRNA or 
H2A.Z2-sgRNA or Scr-sgRNA and the respective repair templates as well as the 
plasmid encoding i53. PolyJet-containing DMEM was replaced with media containing 
200 ng/mL and treated for 20 hours. Fresh media was replaced and the cells were 
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released from cell synchronization for 24 hours before Puromycin selection was 
conducted at 1 ug/mL for 3 days.  
 
2.2.2 DNA analysis: extraction, PCR, restriction enzyme analysis and gel analysis 
 DNA was extracted from clones via the QuickExtract™ DNA Extraction Protocol 
and quantified using the Thermo Scientific NanoDrop 2000/2000c Spectrophotometer. 
Equal concentrations of 500 ng DNA were used in the PCR analysis to determine if 
Strep-tag has been inserted. The primer pairs for H2A.Z1 and H2A.Z2 were both 
designed to amplify the last exon (exon 5) and some region at 3’UTR of H2A.Z1 or 
H2A.Z2, and inclusive of the Strep-tag integration if it had been integrated between the 
last exon and 3’UTR. The primer pair for Strep-tag was designed to target just the 
Strep-tag in the gene. PCRs (0.25 uL Taq polymerase, 5 uL ThermoPol Buffer, 1 uL 
each of forward and reverse primer, and 1 uL of 10mM dNTP per sample) for both 
H2A.Z1 and H2A.Z2 primer pairs were performed under the same conditions except for 
the annealing temperature. PCR products were then purified with the Wizard SV 
Genomic DNA Purification System from Promega. Restriction enzyme digestion was 
performed on H2A.Z1 and H2A.Z2 PCR products with BamHI-HF and 10X CutSmart 
buffer in 37℃ for 3 hours. Larger PCR products were run on a 1% agarose gel with 
RedSafe while smaller PCR products were run on 10% TBE polyacrylamide gel with 1X 
TBE buffer at 150 volts for 50 minutes before soaking it in RedSafe Dye for 20 minutes. 
The gel was washed in ddH2O 3 times for a minute each before exposure to UV light to 
observe bands. 
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2.2.3 Western blot analysis 
  For whole cell protein extraction, boiling hot (@95℃) 2x sample buffer (SB) was 
added to the cell pellets and immediately mixed. They were then sonicated at 35% duty 
cycle and 40% output control 13 pulses. The samples were then centrifuged at high 
speed and the supernatant was transferred to new tubes. Samples were then stored at -
20℃ or used in subsequent Western blot analyses. To obtain proteins from nuclear 
extract, cell pellets were washed with Buffer A and lysed with Buffer A + 0.1% Triton-
X100 for 5 minutes on ice. The samples were spun at 1300G for 5 minutes at 4℃ and 
the supernatant containing the cytoplasmic fraction was removed. Nuclear fraction was 
lysed with boiling hot 2x sample buffer (SB) and sonicated. The protein samples were 
either stored at -20℃ or used in subsequent Western blot analyses.  
 
 Protein samples were loaded in 15% polyacrylamide gels when blotting for 
histones or 10% polyacrylamide gels when blotting for higher molecular weight proteins. 
SDS gel-electrophoresis was conducted at 150V for 17 minutes and 200V for 58 
minutes in SDS running buffer. The proteins separated on the SDS gels were 
transferred to PVDF membranes using semi-dry when detecting for low molecular 
weight proteins, or wet transfer apparatus when detecting for high molecular weight 
proteins. The PVDF membranes were then blocked in 5% milk in TBS-T for 1 hour at 
room temperature (RT), and blotted with incubated with appropriate primary antibodies 
overnight at 4℃ in 2% milk with TBS-T. Strep-tag II antibody was used to detect the 
Strep-tagged H2A.Z isoforms. In addition, three other antibodies were used to detect 
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the endogenous as well as tagged H2A.Z isoforms: Active motif H2A.Z and antibody 
#1379 (previously made in the lab) recognize the C-terminus of H2A.Z, whereas 
antibody #1380 (also previously made in the lab) is directed against the L1 loop of the 
H2A.Z histone variant. The endogenous H2A.Z isoforms should be detected as a 14 
kDa band on the Western blot, whereas the Strep-tagged form should have an apparent 
molecular weight of 15 kDa. The ubiquitylated form of H2A.Z or H2A.Z-Strep should be 
detected as bands at 22 kDa or 23 kDa respectively. Instead of transferring the SDS gel 
with the separated proteins, some gels were stained in Coomasie B stain for an hour at 
RT for an hour on a shaker and de-stained overnight to use the four histone bands as a 
loading control.  
 
2.2.4 Fluorescence-activated cell sorting (FACS) analysis 
 Cell pellet was obtained after trypsinization of the cells from the cell culture plate 
and was washed in 1 mL of Phosphate-Buffered Saline (PBS) before centrifuging it at 
5000 rpm for 2-5 minutes. PBS was then removed and the pellet was re-suspended with 
300 mL of PBS and adding 700 mL of -20℃ 100% high grade ethanol on ice for 30 
minutes. The resulting samples were then stored in -20℃ until FACS analysis was 
conducted. On the day of FACS analysis, the samples were centrifuged at 1000 rpm for 
5 minutes before removing the supernatant. The pellet for each sample was re-
suspended in 10 mL of cold PBS and centrifuged at 1000 rpm for 5 minutes before 
removing the PBS. The pellet was then re-suspended in 10 mL of staining buffer and 
centrifuged at 1000 rpm for 5 minutes before aspirating the buffer. The resulting pellet 
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was again re-suspending in 1 mL staining buffer with RNaseA at final concentration of 
50ug/ml and propidium iodide at final concentration of 50 ug/mL. The samples were 
then left to incubate in the dark at RT for an hour before conducting FACS analysis in 
the machine. 
 
2.2.5 Reverse transcriptase Quantitative Polymerase Chain Reaction (RT-qPCR) 
 Scrambled, 3 H2A.Z1-Strep, and 3 H2A.Z2-Strep clones were seeded in 60 mm 
plates and RNA was harvested 24 hours after according to the QiaGEN RNeasy kit. 
Once RNA was extracted from the sample, their concentration was determined and 2 ug 
was treated with DNAse1 at 37℃ for 10 minutes. The reaction was terminated with 5 
mM EDTA and heated at 75℃ for 10 minutes. First-strand cDNA was synthesized 
initially by addition of 50 uM oligo(dT) and 10 mM dNTP before incubation at 65℃ for 10 
minutes. The samples were then snap-chilled on ice for 5 minutes. First-strand buffer, 
0.1M DTT, and ribonuclease inhibitor were added to the samples and incubated at 50℃ 
for 2 minutes. SuperScript III Reverse Transcriptase was added and incubated at 50℃ 
for 50 minutes. To inactivate the reaction, the samples were heated at 70℃ for 15 
minutes. At the end of the reaction, cDNA was stored at -20℃ until use.  
 
 qPCR was conducted in triplicate with PerfeCta SYBR Green SuperMix (Quanta 
Biosciences) and primers specific to the transcript. Gene expression was normalized 
with the housekeeping gene Cytochrome C.  
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2.2.6 Chromatin immunoprecipitation  
 Cells from two 15-cm cell culture dishes were collected by trypsinization from the 
CRISPR-Cas9 clones; Scrambled, H2A.Z1-Strep #2, H2A.Z2-Strep #5, H2A.Z2-Strep 
#13, and H2A.Z2-Strep #20. Cells were counted to ensure equal amounts were used for 
protein extraction. They were then washed with 10 mL PBS + protease inhibitors (PI) 
and fixed by incubating with 1% formaldehyde in PBS at RT for 30 minutes. 
Formaldehyde treatment was quenched with 125 mM glycine and incubated at RT for 5 
minutes. The fixed cells were then washed 3x in cold PBS + PI and incubated in nuclei 
isolation buffer (50 mM HEPES pH 8.0, 1 mM EDTA, 0.5 mM EGTA, 140 mM NaCl, 
10% glycerol, 0.5% NP-40, 0.25% Triton X-100) + PI for 10 minutes at 4℃ on a nutator. 
Nuclei were pelleted with centrifugation and washed with wash buffer (10 mM HEPES 
pH 8.0, 1 mM EDTA, 05 mM EGTA, 200 mM NaCl) at 4℃. Pelleted nuclei were 
resuspended in sonication buffer (50 mM HEPES pH 8, 1 mM EDTA, 140 mM NaCl, 1% 
Triton-X100, 0.1% SDS, 0.5% SDC) + PI and nutated at 4℃ for 10 minutes. Sonication 
was conducted at 90% duty cycle and 40% output with 8 pulses per cycle and for a total 
of 8 cycles. Samples were chilled on ice 1 minute between each cycle. The samples 
were then centrifuged at max speed at 4℃ for 10 minutes and the supernatants were 
transferred to clean microcentrifuge tubes. To ensure that the amount of input DNA 
were approximately equal for IP, a small aliquot of 50 uL was taken from each sample 
and the remaining was stored at -20℃. To the small aliquot, 250 uL of Elution Buffer 
(2% SDS, 10 mM DTT, 0.1M Sodium Bicarbonate) was used to top up the volume and 
5M NaCl was added before incubation at 65℃ overnight to reverse cross-linking. They 
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were then treated with RNAse A and Protinase K, followed by DNA extraction with 
standard phenol-chloroform protocol and lyophilized in a speed-vac before re-dissolving 
the sample in 50 uL molecular biology-grade water. The DNA concentration from the 
samples were then determined, and 5 ug of chromatin from the remaining sample was 
used for IP. The remaining supernatant were then used pre-cleared with Protein G 
Dynabeads (Invitrogen) for 2 hours at room temperature on a nutator. The samples 
were then incubated with following antibodies overnight at 4℃: Strep-tag, AM H2A.Z, 
and H3. Chromatin-antibody complexes were then pulled down with new Protein G 
Dynabeads for 2 hours at room temperature on a nutator and washed sequentially in 
the following buffers containing PI: RIPA (150 mM NaCl, 50 mM Tris pH 8, 0.1% SDS, 
0.5% SDC), High Salt (500 mM NaCl, 50 mM Tris pH 8, 0.1% SDS), LiCl buffer (250 
mM LiCl, 50 mM Tris pH 8, 0.5% SDC), and 2 washes with TE buffer (10 mM Tris pH 8, 
1 mM EDTA). Chromatin were then eluded from the beads with Elution buffer and DNA 
precipitated as described above. An aliquot of 5 uL for each sample was used in 
triplicates for qPCR analysis described previously with primer pairs targeting the 
promoters of genes known to be enriched by H2A.Z-containing nucleosomes. The gene 
used to normalize ChIP elute samples was the (-)2kb PSA gene that is not enriched by 
H2A.Z. The following primers were then used for ChIP analyses: MTA1 promoter region 
250-350 bp (MTA1 250-350) forward 5’ cctcactgcggaaagagcac 3’, reverse 5’ 
agaggccacctccaaagacc 3’; MTA promoter region 650-700 bp (MTA1 650-700) forward 
5’ gaaatggcccttgtggaggat 3’, reverse 5’ caccagaaccccctggtagat 3’; TRIM21 forward 5’ 
aaactcagtagcccgtggtc 3’, reverse 5’ agcgtctaggtgtggagtga 3’. ChIP data are presented 
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as enrichment to account for any differences in nucleosome density between samples, 
which were calculated by dividing % input of the IPs by the % input of the total H3 IPs.  
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2.3 Results 
2.3.1 Increased HDR efficiency with both i53 and Nocodazole  
 Cas9 endonuclease induces double-stranded breaks (DSBs), leading to DNA 
damage and inducing DNA repair mechanisms; NHEJ or HDR. For efficient insertion of 
Strep-tag into the genome, we require a high proportion of cells to undergo HDR. 
Nocodazole is a drug that arrests cells at G2/M, a phase of the cell cycle that is known 
to have a higher HDR rate in response to DNA damage (Gutschner et al 2016). 
Additionally, i53 is a reagent developed to inhibit the 53BP1 protein that normally 
promotes NHEJ, and enhance HDR efficiencies instead. To examine the effects of i53 
and Nocodazole on HDR efficiency, 293T cells were transfected with the PX459 
plasmid, encoding both Flag-tagged Cas9 and the sgRNA targeting either H2A.Z1 or 
Scrambled sequences, and the repair template with the H2A.Z1-Strep sequence. The 
Scrambled sgRNA, which would not target Cas9 to the H2A.Z1 allele, was used as a 
negative control for Cas9-mediated modification of the H2A.Z1 gene. Genomic DNA 
was extracted and PCR was used to amplify the region around the site of Strep-tag 
insertion at H2A.Z1 gene. The amount of PCR products corresponding to H2A.Z1 
sequence with the Strep-tag insertion was used as an approximate measurement of 
HDR efficiency (the relative portion of transfected cells having the Cas9-directed 
insertion of the Strep-tag sequence). If majority of the cells underwent the NHEJ 
pathway to repair the DNA damage, we would observe any large insertion into the 
H2A.Z alleles since most break ends are simply re-ligated together. PCR products that 
do not contain Strep-tag insertion would show a smaller band at 508 bp, whereas the 
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presence of Strep-tag insertion would produce a larger 571 bp PCR product. The 
intensity of the band roughly suggests the abundance of the PCR product; the higher 
the intensity of the band, the more abundant it is. Without drug treatment, we observed 
2 bands at 508 bp and 571 bp in the Cas9-H2A.Z1-sgRNA + repair template sample 
(henceforth named as H2A.Z-sgRNA), indicating the presence of both Strep-tagged 
H2A.Z1 and unmodified H2A.Z1 alleles (Figure 2-4). The 571 bp was presumed to 
correspond to the Strep-tag-containing PCR product since it was absent in the samples 
transfected with the Cas9-Scrambled-sgRNA + H2A.Z1 repair template control 
(henceforth named as Scrambled-sgRNA). When the H2A.Z1-sgRNA transfected cells 
were treated with either Nocodazole or i53, there was a small increase in the relative 
abundance of the 571 bp PCR product compared to the no-treatment samples, 
suggesting addition of either reagent slightly improved the efficiency of insertion of the 
Strep-tag sequences. However, we also saw the presence of the 571 bp band in the 
Scrambled-sgRNA-transfected sample treated with Nocodazole or i53.  This was 
unexpected since the Scrambled-sgRNA should not target Cas9 to modify the H2A.Z1 
gene.  We do not have an explanation for this observation but the presence of the 571 
bp band in these samples could be due to a small amount of PCR-template 
contamination. In the conditions where both Nocodazole and i53 were added, the 
sample from cells transfected with the Scrambled-sgRNA control again did not show 
any of the 571 bp product, whereas in the H2A.Z1 sgRNA-transfected sample there was 
a clear reduction of the 508 bp product (corresponding to the unmodified H2A.Z1 allele) 
and a concomitant increase in the 571 bp product (corresponding to the modified allele).  
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Although these results were qualitative and not perfect, they do suggest that the 
combination of both reagents helped improve the efficiency of Cas9-mediated 
modification of the H2A.Z1 allele.  
 
 To further confirm the 571 bp PCR product observed corresponds to alleles that 
have insertion of the Strep-tag DNA sequences, we also performed BamHI restriction 
enzyme digestion of the PCR samples. The Strep-tag insertion should also add three 
BamHI digestion sites (Figure 2-4, red GS) in the linker region between the H2A.Z.1 and 
Strep-tag DNA sequences (lower panel of Figure 2-4). BamHI digestion of the PCR 
samples from Scrambled-sgRNA-transfected cells yielded only one intact band 
corresponding to the expected 508 bp products whereas BamHI digestion of the PCR 
samples from H2A.Z1-sgRNA-transfected cells yielded a main 508 bp band plus a 
smaller size band. BamH1 digestion of the insert-containing (571 bp) PCR product is 
expected to yield two main fragments at 290 bp and 257 bps plus 2 very small 
fragments corresponding to sequences between the tandem BamHI sites.  Although the 
agarose gel shown did not clearly resolve two distinct smaller size DNA bands, the 
presence of the smaller size band specifically in the H2A.Z1-sgRNA- but not in the 
Scrambled-sgRNA-samples suggests that the smaller band detected does correspond 
to the BamH1 digested 571 bp PCR product.  In this analysis, we observed slightly 
more of the smaller size BamH1-digested bands in the Nocodazole/i53-treated samples 
compared to the no-treatment sample; however, there was no significant difference in  
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Figure 2-4. Efficiency of Nocodazole and i53 in increasing HDR for CRISPR-Cas9 
insertion of Strep-tag in C-terminus of endogenous H2A.Z1 using semi-
quantitative PCR technique. Scrambled clone was used as a negative control for 
Strep-tag insertion, which was used as a measurement for efficiency of HDR in the 
293T cells. Nocodazole drug was administered to CRISPR-Cas9 transfected cells for 20 
hours, while i53 was co-transfected along with the respective sgRNAs. Genomic DNA 
were extracted from the transfected cell population and PCR was conducted on the 
samples with a pair of primers that encompass part of the C-terminus end of 
endogenous H2A.Z1. Strep tag insertion at the C-terminus would increase the PCR 
product size, indicating by the bigger PCR product. Subsequently, restriction enzyme 
digestion was conducted with BamHI, whose recognition sites are only found in the 
PCR products including Strep-tag. There would be a total of 4 digestion products after 
cleavage, but two would be of tiny fragment size undetectable in the gel analysis.  
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Nocodazole 
& i53
H2A.Z1-GGGSGGGSGGGSA-StrepH2A.Z1
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the amount of the smaller product in the separate or combined Nocodazole/i53 
treatments.  Nevertheless, our results suggest that there may be some benefit using 
Nocodazole and i53, and therefore, we decided to include both treatments in our actual 
experimental attempts to generate cell lines containing Strep-tagged H2A.Z1/H2A.Z2 
alleles.  
 
2.3.2 Generation of Strep-tagged H2A.Z1 & H2A.Z2 clones in 293T cells 
 A modified CRISPR-Cas9 genome editing system was used to insert Strep-tag 
into the 3’ end of the endogenous genes of H2A.Z1 or H2A.Z2 histone variant isoforms, 
H2AFZ and H2AFV (Figure 2-5). PX459 plasmid encoding the Flag-tagged Cas9 with 
sgRNA targeting Scrambled or the 3’ end of either H2AFZ or H2AFV were transfected in 
low passaged 293T cells, along with the corresponding repair template and i53. The 
transfected cells were treated with Nocodazole for 20 hours and then grown in 
Puromycin for three days to select for cells that expressed the PX459 plasmid. Whole 
cell protein lysates were extracted initially from a portion of the cell population to check 
for expression of Cas9 in the cells after Puromycin selection (data not shown), and the 
remaining cells were used in clonal dilution and isolation of individual colonies. Single 
cell colonies were selected and expanded; a portion of each cell clone was 
cryopreserved whereas the rest of the cells were further tested to confirm Strep-tag 
insertion. Preliminary checks at the level of genomic DNA were done by PCR and at the 
protein level by Western blots to screen for colonies that indeed had Strep-tag insertion 
in H2A.Z1 or H2A.Z2. A few rounds of CRISPR-Cas9 transfections were conducted to  
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Figure 2-5. Schematic of the CRISPR-Cas9 genome editing system to insert Strep-
tag to 3’ ends of endogenous H2AFZ AND H2AFV genes. Cells were transfected 
with the plasmids expressing the SpCas9 endonuclease with the respective sgRNA and 
i53 protein, as well as the respective repair template in the form of single stranded 
oligonucleotides (ssODNs). Media was replaced 16-18-hours post-transfection and 
Nocodazole treatment was conducted on the cells for 20 hours. Fresh media was 
replaced to wash away Nocodazole and the cells were treated to puromycin selection 
for 3 days. To relieve cells of stress from the drug treatment, cells were incubated in 
fresh media for a day before conducting serial dilutions in 15 cm dishes. Proteins were 
also extracted to ensure expression of Cas9 endonuclease. Clonal isolation was 
conducted over 3 weeks and single cells were selected and transferred to 24-well plates 
and expanded over 1-2 weeks. Once there would be enough cells, these selected single 
clones would have their DNA extracted for confirmation of Strep-tag insertion at the 
correct site and the remaining cells would be cryopreserved. Once DNA analysis 
showed positive clones for Strep-tag insertion, these clones would be taken from 
cryopreservation and cultured for protein analysis of Strep-tagged H2A.Z isoforms by 
Strep-tag antibody. 
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obtain clones that contain insertion of Strep-tag sequences at the 3’ end of the 
endogenous H2A.Z1 or H2A.Z2 genes. After a few failures in the puromycin selection 
step and the isolation of clones, we finally obtained viable clones that were expanded. A 
total of 54 clones were collected; 26 H2A.Z1-Strep clones, 23 H2A.Z2-Strep clones, and 
5 Scrambled clones. Genomic DNA was extracted from these surviving clones that 
potentially have either H2A.Z1-Strep or H2A.Z2-Strep endogenous genes. PCR was 
conducted with primer pairs that amplified the 3’ end of either H2A.Z1 or H2A.Z2 and 
restriction enzyme digestion was conducted with BamHI to cleave sites only found in the 
inserted DNA sequence (Figure 2-6A). Before cleavage, we can clearly observe the 
band at 508 bp for unmodified H2A.Z1 in the negative controls, Scrambled and 293T, as 
well as in H2A.Z1-Strep #2, and a slightly larger band at 571 bp was observed in all 3 
H2A.Z1 clones (Figure 2-6B). H2A.Z2 clones all showed the slightly larger band at 493 
bp indicating Strep-tag insertion, and the 430 bp band for unmodified H2A.Z2 was 
observed in both the negative controls and H2A.Z2-Strep #5 (Figure 2-6C). The 
presence of the two bands suggested heterogeneity of both unmodified and modified 
H2A.Z1 and H2A.Z2 alleles respectively, indicating these two clones might be 
heterozygous for Strep-tag insertion. After cleavage, we see that there were 3 positive 
clones for H2A.Z1-Strep, clone #2, #3, #5, that showed cleavage products at 290 and 
257 bp (Figure 2-6D). In addition, there is also a band at 508 bp in H2A.Z1-Strep #2 
clone aligned to the band observed with the Scrambled-sgRNA negative control, which 
suggested a heterozygous nature of the insertion. BamHI restriction digest in H2A.Z2-
Strep clones showed cleaved PCR products at 260 bp and 209 bp in 4 of the clones;  
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Figure 2-6. Confirmation of Strep-tag insertion at the C-terminus of endogenous H2A.Z1 
or H2A.Z2 using PCR and restriction enzyme digestion. A) Genomic DNA were extracted 
from the obtained viable clones and PCR was conducted with primer pairs targeting similar 
regions in H2A.Z1 for potential H2A.Z1-Strep clones and in H2A.Z2 for potential H2A.Z2-Strep 
clones. Scrambled clones were used as negative controls for Strep-tag insertion as well as for 
unmodified H2A.Z isoforms. B) PCR was conducted with H2A.Z1-targeting primers. Strep-tag 
inserted clones showed a bigger band at 571 kDa in comparison to Scrambled and 293T at 508 
kDa. C) Restriction enzyme digestion with BamHI showed 3 clones #2, #3, and #5, containing 
Strep-tag insertion as there were products of cleavage at 290 kDa and 257 kDa. H2A.Z1-Strep 
clone #2 contains an additional band at 508 kDa after cleavage. D) PCR was conducted with 
H2A.Z2-targeting primers. Strep-tag inserted clones showed a bigger band at 493 kDa in 
comparison to the negative controls, Scrambled and 293T, at 430 kDa. E) Restriction enzyme 
digestion with BamHI also showed 3 clones #5, #13, #15, and #20 had Strep-tag insertion to 
H2A.Z2 with cleavage products showing at 260 kDa and 209 kDa. H2A.Z2-Strep clone #5 and 
#15 contains an additional band at 508 kDa after cleavage. 
H2A.Z1-Strep
H2A.Z1 H2A.Z2-StrepH2A.Z2
3linker-Strep
Exon	4 Exon	5 3’	UTR Exon	4 Exon	5 3’	UTR
Forward	primer Reverse	primer Forward	primer Reverse	primer
BamHI cut	sites
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#5, #13, #15, and #20, suggesting Strep-tag insertion (Figure 2-6E). The lack of the 
larger band representing unmodified H2A.Z1 or H2A.Z2 in both H2A.Z1-Strep #3 and #5 
as well as in H2A.Z2-Strep #13 and #20 supported the homogeneity of modified H2A.Z1 
or H2A.Z2.  We next wanted to confirm Strep-tag integration again by replacing the 
reverse primer with one that recognizes a site directly on the Strep-tag (Figure 2-7A). 
The negative control, Scrambled, showed an absence of band as the reverse primer 
was unable to anneal for amplification (Figure 2-7B). All H2A.Z1-Strep clones and 
H2A.Z2-Strep clones showed a band at 314 bp and 266 bp respectively indicating 
Strep-tag presence, except for H2A.Z2-Strep #15 clone. Moving forward, we decided 
not to use H2A.Z2-Strep #15.  
 
 To confirm Strep-tag insertion at the level of protein expression, whole cell 
lysates were used for Western blot analysis using a commercial antibody against the 
Strep-tag.  Lysates from cells transfected with a Strep-tagged H2A.Z-expression 
construct were included as a positive control for Western blot detection in the initial 
round of protein analysis (Figure 2-8, represented by the +). Bands corresponding to the 
expected sizes of H2A.Z-Strep (~ 14 kDa) and ubiquitylated H2A.Z-Strep (~ 22 kDa) 
proteins were detected by the Strep-tag antibody in all the clones deemed positive for 
Strep-tag insertion by DNA analysis for both H2A.Z1 (Figure 2-8A) and H2A.Z2 (Figure 
2-8B). Additionally, the levels for H2A.Z1-Strep clone #2 and H2A.Z2-Strep clone #5 
were clearly lower than other positive clones within their own class, supporting the 
previous interpretation that those 2 clones are heterozygous for Strep-tag insertion.  
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Figure 2-7. Confirmation of Strep-tag insertion at the C-terminus of endogenous 
H2A.Z1 or H2A.Z2 using PCR with reverse primer directly against the Strep-tag. 
(A) Genomic DNA were extracted from chosen clones and PCR was conducted with 
either H2A.Z1 or H2A.Z2 forward primer and a reverse primer targeting the Strep-tag 
sequence directly. (B) Should Strep-tag not be inserted at the C-terminus of H2AFZ OR 
H2AFV in the respective clones, a PCR product would not be observed as the reverse 
primer would be unable to recognize any sequence and anneal to the genome for 
amplification. Additionally, Scrambled acts as the negative control as there should not 
be any Strep-tag inserted. A band was observed in all the H2A.Z1-Strep and H2A.Z2-
Strep clones except in H2A.Z2-Strep #15. The specificity of these band was validated 
when there was no band observed in Scrambled.  
	
	
	
	
	
	
Table 2-1. Summary of the Strep-tagged H2A.Z1 and H2A.Z2 clones obtained. A 
total of 3 clones each were obtained for both isoforms. Each isoform has 1 
heterozygous Strep-tag insertion and 2 homozygous. 
 
  
3linker-Strep
Exon	4 Exon	5 3’	UTR Exon	4 Exon	5 3’	UTR
Forward	primer Forward	primer Reverse	primer
H2A.Z1-Strep	clones H2A.Z2-Strep	clones
Heterozygous	 #2 #5
Homozygous #3
#5
#13
#20
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Figure 2-8. Confirmation of Strep-tag insertion at the C-terminus of endogenous 
H2A.Z1 or H2A.Z2 using Western-blot analysis with Strep-tag antibody. Western 
blot analyses of proteins from the whole-cell lysates from the identified Strep-tag 
positive clones with Strep-tag antibody. The positive control for H2A.Z-Strep was 
obtained from cells overexpressing the H2A.Z1-Strep protein. (A) H2A.Z1-Strep clones 
show presence of Strep-tag indicating H2A.Z1-Strep and ubiquitylated H2A.Z1-Strep. 
(B) H2A.Z2-Strep clones show presence of Strep-tag indicating H2A.Z2-Strep and 
ubiquitylated H2A.Z2-Strep, albeit at much lower levels. 
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Overall, we successfully obtained 6 Strep-tag inserted clones from the 48 clones 
selected. PCR and protein analyses suggested that H2A.Z1-Strep #2 and H2A.Z2-Strep 
#5 were clones with heterozygous insertion of the Strep-tag sequences where H2A.Z1-
Strep #3, H2A.Z1-Strep #5, H2A.Z2-Strep #13, and H2A.Z2-Strep #20 were clones with 
homozygous insertions (Table 2-1). 
 
 Nuclear extract from all 6 positive clones as well as from the negative control 
(Scrambled-sgRNA-transfected) clones were obtained and analyzed again by Western 
blot with all the samples ran in parallel to compare their expression levels. H2A.Z2-
Strep levels were detected by the Strep-tag antibody at much lower levels than H2A.Z1-
Strep, which is consistent with the known lower RNA expression of H2A.Z2 compared to 
H2A.Z1 (Figure 2-9). Also as expected, the heterozygous clones for both H2A.Z1-Strep 
and H2A.Z2-Strep had approximately half the amount of the tagged histones (detected 
by the Western blots) compared to the homozygous clones. H2A.Z2-Strep clones had a 
much lower expression detected in the Strep-tag blots, indicating that H2A.Z2 seemed 
to be expressed at a much lower rate than H2A.Z1. Flag-tag antibody was also used to 
probe for the presence of Cas9 endonuclease, and H2A.Z1-Strep #3 was the only clone 
that still expressed Cas9.  Since the transfected cells were selected with puromycin for 
only 3 days, it is possible that Cas9 expression was eventually lost in most of the clones 
after multiple cell passages without selection. The presence of Cas9 in H2A.Z1-Strep #3 
might result in off-target cleaving and lead to potential genome mutations. Finally, when 
blotted with two different H2A.Z antibodies, expression of H2A.Z was found to greatly  
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Figure 2-9. Strep-tag is successfully inserted to endogenous genes of H2A.Z1 and 
H2A.Z2. Western blot analysis of nuclear lysates from H2A.Z1-Strep and H2A.Z2-Strep 
clones, as well as the Scrambled clones. Coomasie was used as loading control and 
showed approximately equal loading of proteins. Strep-tag antibody was used to blot for 
the tag, while AM H2A.Z and 1380 antibodies were used to detect the H2A.Z1 proteins, 
both modified and unmodified. Flag antibody was used to detect the presence of Cas9 
nuclease that is tagged with Flag. Heterozygous clones are color-coded in blue label 
while the homozygous clones are in orange.  
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reduced in the homozygous H2A.Z1-Strep clones compared to controls of H2A.Z2-Strep 
clones.  Since the same observation was seen with two separate antibodies directed at 
different regions of the H2A.Z protein, this suggested the lack of detectable H2A.Z in the 
H2A.Z1-Strep clones was due to a knockdown of expression rather than an epitope 
occlusion (the inserted tag blocking recognition by the antibody) problem.  Instead, it 
appears that the DNA sequence inserted right before the stop codon of the endogenous 
H2A.Z1 gene may have affected its expression at either the transcription, mRNA 
stability, or protein translation levels.   
 
2.3.3. Lower endogenous H2A.Z2 protein levels in comparison to H2A.Z1 in 293T cells 
 The difference in the levels of H2A.Z1-Strep and H2A.Z2-Strep proteins as 
detected by Strep-tag antibody versus endogenous H2A.Z antibodies suggested that 
Strep-tag antibody is more sensitive at detecting the tagged proteins. However, 
endogenous H2A.Z antibodies are used for detecting the H2A.Z1 isoform. As H2A.Z1 
isoform in H2A.Z2-Strep clones are unmodified, their levels were still detectable by the 
endogenous H2A.Z antibodies in the clones. Strep-tag antibody measures the levels of 
H2A.Z1 protein in H2A.Z1-Strep clones and H2A.Z2 protein in H2A.Z2-Strep clones. 
Data showed that H2A.Z2 seems to be expressed at a much lower level than H2A.Z1 as 
indicated by the intensity of the bands (Figure 2-9). We wanted to get an estimate 
difference in protein expression levels between the two histone variant isoforms in 293T 
cells. The heterozygous H2A.Z1-Strep #2 clone had comparable H2A.Z1 signal picked 
up by Strep-tag antibody that was not too intense when compared to H2A.Z2 levels in 
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H2A.Z2-Strep clones, and was hence used as a comparison. Furthermore, endogenous 
H2A.Z antibodies were still able to detect some levels of H2A.Z1 protein expression 
levels in the heterozygous H2A.Z1-Strep #2 clone. Nuclear extracts from H2A.Z1-Strep 
#2 and the H2A.Z2-Strep clones were obtained and analyzed with Western blot. 
Dilutions of H2A.Z1-Strep #2 were conducted by taking 1/3 th, 1/6 th. 1/9 th, and 1/12th of 
the sample and diluting it with 2x SB and protein loading dye to equalize the loading 
volume. We observed that H2A.Z1 levels at 1/9th or 1/12th showed similar band intensity 
to H2A.Z2 (Figure 2-10). This suggested that H2A.Z2 is expressed 1/18th or 1/24th lower 
than H2A.Z1 in 293T cells, as we are comparing heterozygous H2A.Z1-Strep levels to 
H2A.Z2-Strep levels and we have assumed that the homozygous clones have twice the 
number of modified alleles than heterozygous clones.  
 
2.3.4 Characterization of H2A.Z1-Strep and H2A.Z2-Strep clones 
 Protein analysis showed a reduction in endogenous H2A.Z1-Strep levels. 
However, we do not know at which stage its gene expression was altered. To test 
whether insertion of the Strep-tag sequence affected the transcription rate of the 
H2A.Z1 and H2A.Z2 genes, we next used reverse transcriptase quantitative PCR (RT-
qPCR) to measure the steady-state amount of H2A.Z1-Strep/H2A.Z2-Strep mRNA in 
the stable cell clones. Stable cells transfected with the Scrambled-sgRNA was also 
used as a negative control to test whether Cas9 expression affects H2A.Z1/2 
transcription. Finally, normal 293T cells that haven’t been through the CRISPR/Cas9 
editing were used to determine the normal steady-state expression levels of the H2A.Z  
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Figure 2-10. Endogenous H2A.Z2 is expressed at a lower level compared to 
endogenous H2A.Z1. Nuclear extracts from heterozygous H2A.Z1-Strep #2 clone and 
H2A.Z2-Strep clones were obtained and ran in a Western blot and Coomasie for loading 
control. Strep-tag antibody was used to detect Strep-tagged H2A.Z1 or H2A.Z2. 
Heterozygous H2A.Z1-Strep #2 was diluted accordingly and used as a comparison for 
H2A.Z1 protein levels versus H2A.Z2 protein levels. Heterozygous clones are color-
coded in blue label while the homozygous clones are in orange. 
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variant genes. RNA was harvested from the various cell clones and H2A.Z1/2 mRNA 
was converted to cDNA for use in qPCR. H2A.Z1 expression levels in most of the Strep-
tagged clones were comparable to 293T, with a few exceptions. Scrambled and 
H2A.Z2-Strep #5 seemed to have a relatively higher H2A.Z1 expression compared to 
293T, while H2A.Z1-Strep #5 has a lower H2A.Z1 expression levels (Figure 2-11A). 
H2A.Z2 expression levels in all the Strep-tagged and Scrambled sg-RNA clones 
seemed to be similar to levels in 293T cells (Figure 2-11B). The detection of mRNA 
expression levels of H2A.Z1 and H2A.Z2 indicates that the genes were being 
transcribed; however, the data did show some reduction in homozygous H2A.Z1-Strep 
mRNA levels compared to H2A.Z1 expression in normal 293T cells. Additionally, we 
wanted to see if modifying the genome by insertion of Strep-tag would have disrupted 
the cell cycle progression of the clones, and FACS analysis was conducted. Most of the 
clones and Scrambled had the same trend as 293T, with most of the cell population at 
G1 phase, followed by the G2/M phase (Figure 2-12). This suggests that insertion of 
Strep-tag or modification of the genome by Cas9 did not affect cell cycle progression of 
the cells. Altogether, our data suggest that although the H2A.Z2-Strep clones seem to 
be comparable to the unmodified parent cells, the H2A.Z protein levels in the 
homozygous H2A.Z1-Strep clones were undetectable with endogenous H2A.Z 
antibodies and this effect could not be fully explained by transcription rate alone.  
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Figure 2-11. Mostly normal levels of H2A.Z1 and H2A.Z2 mRNA expression in 
H2A.Z1-Strep and H2A.Z2-Strep clones. 293T was both used as a control to compare 
expression of mRNA in Strep-tagged clones. RNA was extracted from cells and 
converted to cDNA with reverse transcriptase for use as template for quantitative PCR 
(qPCR). Each PCR reaction was performed in triplicates. Asterisks show significant 
difference between the sample and the control (293T). A) H2A.Z1 primer pair was used 
to detect relative H2A.Z1 expression levels. B) H2A.Z2 primer pair was used to detect 
relative H2A.Z2 expression levels. Heterozygous clones are color-coded in blue label 
while the homozygous clones are in orange. 
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Figure 2-12. Characterization of cell cycle phases of CRISPR-Cas9 modified 
H2A.Z1-Strep and H2A.Z2-Strep clones by FACs analysis. H2A.Z1-Strep and 
H2A.Z2-Strep clones cells were fixed and stained for analysis in flow cytometry. 293T 
and Scrambled were used as comparison for normal cell cycle phases, with the latter as 
a control for Cas9-modified cells. M1 represents pre-G1 phase, M2 is the G1 phase, M3 
is S phase, and M4 is the G2/M phase. Heterozygous clones are color-coded in blue 
label while the homozygous clones are in orange. 
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2.3.5 Minimal off-target effects using CRISPR-Cas9 for insertion of Strep-tag into C-
terminus of H2A.Z histone variant isoforms in 293T cells  
 We wanted to ensure there weren’t any single base mutation/deletion near the 
site of insertion in our clones, which might also explain the reduced levels of H2A.Z 
detected by the endogenous H2A.Z antibodies in homozygous H2A.Z1-Strep clones. 
Due to time constraints and a failed attempt to sequence the genomic DNA of the 
clones, we utilized an assay that would give us an overview of the presence of 
mutations. Surveyor mutagenesis assay was conducted in the 3 H2A.Z1-Strep clones 
and 3 H2A.Z2-Strep clones with Scrambled-sgRNA as a control (Figure 2-13). 293T 
cells was used as our reference sample as it is the parent cell line of our clones and 
should mimic unmodified H2A.Z1 or H2A.Z2 gene sequences. DNA was extracted from 
our reference sample and both the H2A.Z1-Strep clones and H2A.Z2-clones. PCR was 
conducted with the same primer pairs as described above in Figure 2-7A for both 
H2A.Z1 and H2A.Z2 gene sequences. The PCR products from H2A.Z1-Strep or 
H2A.Z2-Strep clones were then denatured and annealed with the H2A.Z1 or H2A.Z2 
PCR product from 293T to form hetero/homo duplexes. Scrambled, used as a negative 
control, should not show any cleavage bands for both H2A.Z1 and H2A.Z2 when 
hybridized with the reference as the locus should not be targeted by Cas9 and therefore 
won’t be modified (i.e. should have identical DNA sequence). Presence of Strep-tag 
would yield heteroduplexes containing a mismatch at the site of Strep-tag insertion to 
show 2 cleavage bands while absence of Strep-tag would produce homoduplexes and 
not yield any cleavage bands (Figure 2-13). Additionally, any mutations resulting from  
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Figure 2-13. Concept of Surveyor mutagenesis assay in determining off-target 
effects by CRISPR-Cas9 genome editing system when inserting Strep-tag into C-
terminus of H2A.Z histone variant isoforms. Genomic DNA was used in PCR to 
amplify the H2A.Z1 region for H2A.Z1-Strep clones and H2A.Z2 region for H2A.Z2-
Strep clones. Scrambled and 293T cells were also used to amplify H2A.Z1 or H2A.Z2 
region as negative control for Strep-tag insertion and as reference sample respectively. 
After amplification, the PCR products from the Strep-tag clones were incubated with the 
PCR product from the reference gene (H2A.Z1 or H2A.Z2 in 293T) for hybridization; 
H2A.Z1-Strep clones were incubated with H2A.Z1 gene while H2A.Z2-Strep clones 
were incubated with H2A.Z2 gene. After Surveyor nuclease cleavage, there would be 2 
bands observed if Strep-tag was inserted, and more than 2 bands if there were any off-
target effects resulting in mutations. If Strep-tag was not inserted and no off-target 
effects, there would not be a cleavage band.  
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Cas9 off-target effects within the PCR product would also result in heteroduplex 
formation with PCR product from the reference sample. However, this would yield 
different sized bands or more than 2 bands as mutations are random and would occur 
indiscriminately, potentially leading to more sites of mismatches for Surveyor nuclease 
to cut. Surveyor nuclease would then cleave the heteroduplexes, and the digested DNA 
products were analyzed with gel electrophoresis. For H2A.Z1-Strep clones, we 
observed a thick cleavage band at similar size across samples that could be 2 
unresolved bands absent in the negative control (Figure 2-14A, red asterisk), 
suggesting Strep-tag insertion to H2A.Z1 alleles. The PCR products from the clones 
without the reference sample were also ran on a gel alongside the samples hybridized 
with the reference to ensure that the cleavage bands observed were specific to the 
formation of heteroduplexes. The absence of any cleavage bands in the H2A.Z1-Strep 
clones without the reference sample supported the specificity of the cleavage bands 
observed earlier with the reference sample. Two cleavage bands were observed in all 
three H2A.Z2-Strep clones after Surveyor mutagenesis assay that were absent in the 
negative control (Figure 2-14B, red asterisk). However, in the control assay without the 
hybridization with the gene from reference sample, the same two bands were observed 
in H2A.Z2-Strep #5 and H2A.Z2-Strep #20. This suggests that the two cleavage bands 
observed with hybridization might not have been very specific to heteroduplex formation 
from Strep-tag insertion, and there could be slight mutations. This assay was conducted 
only once and should be replicated again to ensure reliability of results. 
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Figure 2-14. No significant mutations observed in H2A.Z1-Strep and H2A.Z2-Strep 
clones. Surveyor mutagenesis assay was carried out as described in the previous 
figure on the 3 H2A.Z1-Strep clones and 3 H2A.Z2-Strep clones, with Scrambled as a 
control to assure any digested bands observed were not random. 293T was used as the 
reference sample. Red asterisk was used to represent the cleavage bands not observed 
in Scrambled control. A) H2A.Z1 PCR product from the reference sample was 
hybridized with H2A.Z1 PCR products from the clones. Cleavage products by Surveyor 
enzyme was run on 10% polyacrylamide gel.  B) H2A.Z2 PCR product from the 
reference sample was hybridized with H2A.Z2-PCR products from the clones. Cleavage 
products by Surveyor enzyme was run on 10% polyacrylamide gel. Heterozygous 
clones are color-coded in blue label while the homozygous clones are in orange. 
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2.3.6 Comparison of localization of H2A.Z1-Strep-containing vs H2A.Z2-Strep-contaiing 
nucleosomes on specific DNA sequences in vivo  
 We next wanted to confirm if the Strep-tagged H2A.Z1 and H2A.Z2 clones are 
incorporated into chromatin and at genomic locations/genes where H2A.Z is known to  
be present (e.g. based on previous ChIP-Seq data). The homozygous H2A.Z1-Strep 
clones #3 and #5 were not used as the levels of H2A.Z1-Strep in these seemed to be 
extremely low as endogenous H2A.Z antibodies were unable to detect it. ChIP was 
conducted using Scrambled, H2A.Z1-Strep #2, and all 3 H2A.Z2-Strep clones to 
examine the localization of the Strep-tagged H2A.Z1 or H2A.Z2 at specific promoters of 
genes. Chromatin was immunoprecipitated using the Strep-tag antibody to isolate for 
chromatin enriched by either H2A.Z1-Strep or H2A.Z2-Strep. They were then probed 
with primer pairs that were previously designed to amplify the MTA1 gene and the 
TRIM21 gene.  For the MTA1 gene, two sets of PCR primers were used corresponding 
to two different regions at different distances from the TSS (Figure 2-15A). These genes 
were formerly identified with RNA-sequencing to have changes in its expression after 
H2A.Z1 knock-down (previously conducted in our lab) and reported to have enriched 
H2A.Z by ChIP experiments. Scrambled-sgRNA sample pulled-down with Strep-tag 
antibody was used to mimic a no antibody control for Strep-tag ChIP as there is no 
Strep-tag present for the antibody to pull-down. H2A.Z1-Strep enrichment was found on 
the MTA1 gene at a more proximal region to its TSS, but this enrichment was not 
observed with the H2A.Z2 clones (Figure 2-15B). There was not any significant 
enrichment of either H2A.Z1-Strep or H2A.Z2-Strep on the distal region of MTA1 gene  
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A.  
 
 
 
 
 
  
 
 
Figure 2-15. H2A.Z1 is highly enriched on MTA1 at the proximal region to its TSS 
compared to H2A.Z2 and equal levels of enrichment between H2A.Z1 and H2A.Z2 
on the distal region of MTA1 TSS. Heterozygous H2A.Z1-Strep #2 and all three 
H2A.Z2-Strep clones were fixed in 1% formaldehyde and nuclear fraction material were 
extracted to use in chromatin immunoprecipitation (ChIP) with Strep-tag antibody. 
Scrambled is used to mimic a no-antibody control as there are no Strep-tag for the 
antibody to IP. A) The two primer pairs used in qPCR correspond to different regions of 
the MTA1 gene. B) ChIP analysis of H2A.Z1-Strep and H2A.Z2-Strep at the proximal 
region of MTA1 transcription start site (TSS). C) Data from A was divided by the data 
from H3 ChIP to account for any changes nucleosomal density across samples. D) 
ChIP analysis of H2A.Z1 and H2A.Z2 at the distal region of MTA1 TSS. E) Data from C 
was divided by the data from H3 ChIP to account for any changes nucleosomal density 
across samples. Heterozygous clones are color-coded in blue label while the 
homozygous clones are in orange. 
ATG MTA1
-371-450-786-896
ProximalDistal
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Figure 2-16. No difference in localization of H2A.Z1 and H2A.Z2 at TRIM21 gene. 
Heterozygous H2A.Z1-Strep #2 and all three H2A.Z2-Strep clones were fixed in 1% 
formaldehyde and nuclear fraction material were extracted to use in chromatin 
immunoprecipitation (ChIP) with Strep-tag antibody. Scrambled is used to mimic a no-
antibody control as there are no Strep-tag for the antibody to IP. A) ChIP analysis of 
H2A.Z1 and H2A.Z2 at the TRIM21 gene. B) Data from C was divided by the data from 
H3 ChIP to account for any changes nucleosomal density across samples. 
Heterozygous clones are color-coded in blue label while the homozygous clones are in 
orange. 
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TSS (Figure 2-15D) nor at TRIM21 (Figure 2-16A). To ensure that the data we observed 
was not due to uneven nucleosome density between the samples, we’ve normalized the 
H2A.Z1-Strep/H2A.Z2-Strep enrichment over the H3 levels. After normalization of the 
data, H2A.Z1-Strep is still more enriched on the proximal region of the MTA1 gene TSS 
in comparison to H2A.Z2-Strep (Figure 2-15C). There weren’t any significant changes in 
the localization between H2A.Z1-Strep and H2A.Z2-Strep on the distal site of the MTA1 
gene TSS (Figure 2-15E) and on TRIM21 gene (Figure 2-16B). My data seemed to 
suggest that H2A.Z1-Strep and H2A.Z2-Strep may have different enrichment levels or 
patterns. However, we need to check/compare the H2A.Z1-Strep and H2A.Z2-Strep 
protein levels in the different clones to rule out differences of ChIP results was due to 
difference in H2A.Z1-Strep/H2A.Z2-Strep protein levels.	Additionally, this was 
conducted only once and should be replicated again to ensure the data observed are 
consistent and accurate.  
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2.4 Discussion	
 The highly conserved H2A.Z variant of the core histone H2A has been implicated 
in transcription regulation. The two recently discovered isoforms, H2A.Z1 and H2A.Z2, 
were found to localize on promoters and regions flanking transcription start sites, 
consistent with their involvement in transcription activation. The goal of this project is to 
insert the Strep-tag DNA sequence in frame to the 3’ terminus of endogenous H2A.Z1 
or H2A.Z2 coding sequences using the CRISPR-Cas9 genome editing system. We 
aimed to address the problem of there being no commercial antibodies that can 
distinguish between the two histone variant isoforms. Fusion proteins that can be 
detected by antibodies against the tag can be expressed, and studies can be done to 
learn more about the distinct functions of the two isoforms. To increase the efficiency of 
the genome editing system, we wanted to increase efficiency of the HDR pathway in 
response to double-stranded breaks for better incorporation of Strep-tag in the repair 
templates. A drug and an inhibitor, Nocodazole and i53 respectively, were both used as 
it seemed to show a cleaner and more efficient Strep-tag insertion when used together 
rather than individually.  
 
 We generated 293T clones that contained Strep-tag in the 3’ terminus of H2AFZ 
and H2AFV genes. For endogenous Strep-tagged H2A.Z1, H2A.Z1-Strep #2 is the 
heterozygous clone for Strep-tag insertion while H2A.Z1-Strep #3 and #5 are 
homozygous for the insertions. For endogenous Strep-tagged H2A.Z2, H2A.Z2-Strep #5 
clone is heterozygous while H2A.Z2-Strep #13 and #20 are homozygous for Strep-tag 
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insertion. These positive H2A.Z1-Strep and H2A.Z2-Strep clones were confirmed at the 
DNA level with PCR and at the protein level with Western blot against the Strep-tag, 
which showed presence of the protein and its ubiquitylated form. H2A.Z2 is seemingly 
expressed at around 18 to 24 times lower compared to H2A.Z1 based on Strep-tag 
antibody detection. Endogenous H2A.Z antibodies that detect H2A.Z1 levels in the cells 
were able to detect normal levels in H2A.Z2-Strep clones, but was unable to pick up a 
signal in the homozygous H2A.Z1-Strep clones, and a weak signal in the heterozygous 
H2A.Z1-Strep #2 clone. This itself might suggest that expressing Strep-tag at the C-
terminus of H2A.Z1 might have knocked out H2A.Z1-Strep in homozygous clones by 
interfering with its gene expression. However, we know that there is detectable amount 
of H2A.Z1 protein in the homozygous clones based on Strep-tag blots, which suggests 
that Strep-tag antibody is more sensitive than the H2A.Z antibodies. This indicates that 
H2A.Z1 expression in homozygous is not knocked out, but potentially severely 
diminished. Additionally, knockout of H2A.Z1 is unlikely as studies have shown that 
H2A.Z1 deficiency is either lethal (Faast et al, 2001) or results in distinct alterations in 
cells (Matsuda et al, 2010). However, the clones were still viable and surviving. 
Although H2A.Z1 levels in all H2A.Z2-Strep clones seem to be normal, we do not know 
for sure if inserting Strep-tag to the C-terminus of H2A.Z2 has affected its protein 
expression as the endogenous H2A.Z antibodies are for detecting H2A.Z1 and not 
H2A.Z2.  
 
 To observe steady state amounts of mRNA of H2A.Z1 and H2A.Z2 in H2A.Z1-
Strep clones and H2A.Z2-Strep clones, RT-PCR was conducted to provide a general 
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sense of RNA expression levels. The relative mRNA expression levels of H2A.Z1 and 
H2A.Z2 in the respective clones showed close to normal expression levels with a few 
exceptions, whereby 293T was used as normalization. H2A.Z1-Strep #5 had higher 
than normal and H2A.Z2-Strep #5 had lower than normal levels of H2A.Z1 mRNA 
transcribed. Relative mRNA expression was still observed in all clones, which supports 
the fact that H2A.Z1 should not have been knocked out, but that there might be some 
problems after transcription of the tagged genes. H2A.Z2 mRNA levels in all the Strep-
tagged clones seem to be relatively comparable to the levels in 293T. Cell cycle 
progression in the cell population also seemed to be normal for most clones, except for 
H2A.Z1-Strep #5. We checked for mutations that might have led to the H2A.Z 
antibodies being unable to recognize H2A.Z, as Cas9 endonuclease might still be 
present in the cells and cleaving the genome non-specifically. Ideally, sequencing of the 
genomic loci of the H2A.Z1/H2A.Z2 alleles would be conducted to be sure of the correct 
insertions and no addition mutations. Due a failed attempt to do so and time constraints, 
Surveyor mutagenesis assay was instead conducted with 293T as the reference 
sample, but did not seem to show significant variance/mutation in the clones.  
 
 One speculation on why the protein levels of H2A.Z1 decreased drastically when 
Strep-tag was inserted to the C-terminus of H2AFZ could be because Strep-tag might 
be occluding certain regions when folded. A study conducted in Drosophila showed that 
the essential regions for H2A.Z to function properly were in its C-terminus region 
(Clarkson et al, 1999). In lieu with this, the SWR-1 ATPase chromatin remodeling 
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complex was found to target the region at the C-terminus of H2A.Z (Wu et al., 2005) 
and the acidic patch crucial for unique interactions of H2A.Z was found in the C-
terminus in S. cerevisiae (Jensen et al, 2011). These findings highlight the importance 
of the C-terminus in the function of H2A.Z1, which could be blocked by Strep-tag when 
H2AFZ-Strep is expressed and folded in its protein structure. The only other region 
where an epitope tag could be inserted is at the 5’ terminus of the gene. However, the 
challenge in doing so is that there is a splice site located after the first methionine ATG 
codon in the endogenous H2A.Z1 gene. If the Strep-tag sequence was inserted right 
after the first ATG codon, this might alter the normal splicing recognition sites and affect 
its proper splicing. This could pose a bigger problem than the current ones we’re facing, 
and so we decided to continue with our C-terminus Strep-tagged H2A.Z1 and H2A.Z2 
clones instead.  
 
 Although H2A.Z1 protein levels in H2A.Z1 homozygous clones were not detected 
by Western blot analysis using several H2A.Z antibodies, there were still detectable 
H2A.Z levels in the heterozygous H2A.Z1-Strep #2 clone. We decided to use it with 
H2A.Z2-Strep clones to compare the two histone variant isoforms. ChIP was conducted 
to determine if Strep-tagged H2A.Z1 and H2A.Z2 were incorporated into nucleosomes 
and whether they had similar characteristics as their unmodified counterparts. Strep-tag 
ChIP was used to probe for DNA regions occupied by nucleosomes containing either 
H2A.Z1-Strep or H2A.Z2-Strep. The immunoprecipitated chromatin was used in 
quantitative PCR with primers corresponding to the promoters of genes known to be 
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enriched for H2A.Z1-containing nucleosomes, such as MTA1 and TRIM21. H2A.Z1-
Strep was found to be highly enriched at the proximal region on the TSS of the MTA1 
gene in comparison to H2A.Z2-Strep. This might suggest some functional differentiation 
between the two isoforms, but additional biological and technical repeats should be 
done. Additionally, we should also factor in the difference in H2A.Z1-Strep and H2A.Z2-
Strep protein levels between the clones, and the reduced H2A.Z2 protein levels could 
contribute to the differential enrichment observed. On the distal region of the TSS of 
MTA1 gene and on TRIM21, we did not observe any significant differences in 
occupancy by H2A.Z1 and H2A.Z2. In the future, we could probe the 
immunoprecipitated chromatin with more primers targeting different genes that are 
already known to be occupied by H2A.Z1-containing nucleosomes and determine if 
there are other differences between H2A.Z1 and H2A.Z2. However, this experiment was 
only conducted once due to time constraints, and needs to be replicated to state 
anything conclusively. 
   
2.4.1 Future directions and implications 
 Moving forward, we could repeat the Surveyor mutagenesis assay to ensure that 
there are indeed no mutations occurring due to off-target effects by Cas9 at the site of 
Strep-tag insertion. Biological and technical repeats of ChIP qPCR should be conducted 
to ensure the trend we’ve observed is consistently seen. Additionally, we could use a 
more recently optimized CRISPR-Cas9 system to increase the efficiency of positive 
Strep-tagged H2A.Z1 or H2A.Z2 clones in other cell lines that are more difficult to 
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transfect. Instead of using the wild type Streptococcus pyogenes Cas9 (SpCas9), we 
could utilize the genetically modified Cas9 with enhanced specificity (eSpCas9) that has 
been shown to have a higher accuracy at inducing double-stranded breaks with less off-
target effects (Slaymaker et al, 2016). Plasmids encoding eSpCas9 with sgRNA 
targeting either H2A.Z1, H2A.Z2 or Scrambled has already been successfully 
generated. To further increase HDR efficiency for the Strep-tag insertion, we’ve made 
some changes to the single stranded oligodeoxynucleotides (ssODNs) in our repair 
templates for both H2A.Z1-Strep and H2A.Z2-Strep. Currently, the repair templates 
we’ve used have symmetric homology arms, with 35 bp homology on both the 5’ and 3’ 
regions. A recent study suggests that asymmetric single stranded donor DNA seemed 
to be favored for insertions (Liang et al, 2016). New sets of repair templates targeting 
H2A.Z1 or H2A.Z2 have been redesigned to be flanked by asymmetric homology arms; 
with 67 bp on the 5’ end and 35 bp at the 3’ region. Additionally, to lower the chances of 
off-target effects by Cas9, the last nucleotide of the PAM sequences has been replaced 
by a Wobble base pair to prevent re-recognition by the Cas9 endonuclease. Taken 
together, we could use this enhanced system to determine if we could generate 
homozygous Strep-tagged H2A.Z1 and H2A.Z2 clones that mimic unmodified H2A.Z1 
and H2A.Z2 levels in the parent cells. Additionally, we would need assurance that any 
future results obtained about H2A.Z1 and H2A.Z2 from the H2A.Z1-Strep and H2A.Z2-
Strep 293T clones are not cell-line specific but universal. After optimizing our technique, 
it can be used to help elucidate the differential roles of both isoforms in the native 
environment during transcription regulation on chromatin.  
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 The significance of H2A.Z’s role in chromatin structure and function was 
highlighted by the fact that it is essential for viability in higher eukaryotes. It is 
specifically localized at the promoters of many genes in human and yeast. However, the 
mechanisms for the requirement of H2A.Z has yet to be clearly understood. 
Furthermore, the presence of two non-redundant isoforms, H2A.Z1 and H2A.Z2, adds 
another layer to the functional complexity of the H2A core histone variant.  
Understanding the functional difference between these two isoforms might provide 
insight into the dynamic roles of H2A.Z that were observed before the discovery of the 
presence of the H2A.Z2 isoform. This can thus contribute towards learning more about 
its role in epigenetic modifications on gene regulation and therefore, develop targeted 
therapeutic means to combat diseases like cancer. 
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3. Characterization of SUMOylated proteins localized to the transcription start site 
via the Avi-tag BirA system 
3.1 Introduction  
 The solving of the nucleosome structure by crystallography paved the way for a 
better understanding of the interactions holding the nucleosome core particles together 
and how these interactions contribute to the forming of higher order chromatin 
structures (Luger et al, 1997). As histones are highly basic, the histone octamer 
contacts with the negatively-charged phosphate backbone of the DNA. The N-terminus 
of the histones proteins, also known as the N-terminal tails, are extended out of the 
nucleosome particle and the DNA double helix. They are thought to play a role in the 
formation of higher order chromatin structures as they can interact with neighbouring 
nucleosomes. The absence of histone tails in archaea suggests that it was an important 
evolutionary trait that helped in compaction of DNA, as well as in regulation of DNA 
accessibility to nuclear proteins (Malike and Henikoff, 2003). It is now widely known that 
histone post-translational modifications (PTMs) have a role in regulating chromatin 
structure and function. Most of the PTM sites are mainly found on the N-terminal tails 
extending past the DNA double helix, although some modifications can be found on the 
C-terminal tails and within the globular domains. Unlike other histones where their C-
terminus tails are buried in the core of the nucleosome complex, H2A variants have 
both unstructured N- and C-terminal tails extending out of the complex (Corujo & 
Buschbeck, 2018). 
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3.1.1 Post-translational modifications (PTMs) of histones by SUMOylation 
 Histones and proteins can be modified by small chemical groups or via covalent 
binding of small polypeptides. Modifications of core histones by covalent binding of 
small polypeptides could modify properties of the nucleosome unit or the ability of 
certain nuclear proteins to bind with it and; therefore, could play a role to regulate the 
proper functions of chromatin (Lawrence et al, 2016). The most common PTM by 
covalent polypeptide addition is ubiquitin. One of its major roles is to bind to proteins 
and target them for proteolytic degradation by the proteasome. Aside from ubiquitin, 
there are other forms of ubiquitin-like (UBL) proteins that can conjugate to and modify 
the activities of its substrate proteins. SUMOylation, a process where small ubiquitin-like 
modifiers (SUMOs) are covalently attached to or detached from its substrate proteins, is 
another form of PTM. Studies have observed that these 13 kDa SUMOs conjugate to a 
large variety of proteins that function in important cellular processes such as 
transcription regulation and nuclear localization (Flotho and Melchior, 2013). SUMO and 
ubiquitin are similar in their structure (Bayer et al, 1998), but the distribution of the 
charged residues on both polypeptides are different. These surface residues contribute 
to the binding specificities that differ between ubiquitin and SUMO (Gill, 2004). 
Vertebrates, such as humans, express 4 paralogs of the SUMO protein, SUMO-1, 
SUMO-2, SUMO-3, and SUMO-4 while invertebrates express a single SUMO 
(Kerscher, 2007 OR). SUMO-2 and SUMO-3 proteins were found to share 
approximately 97% sequence identity and are commonly referred to as SUMO-2/3 
(Wang and Dasso, 2009). SUMO-2/3 also share approximately 86% with SUMO-4, but 
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much is unknown about the ability of SUMO-4 to conjugate to other proteins (Owerbach 
et al, 2005; Wei et al, 2008 OR). On the other hand, they only share about 50% identity 
with SUMO-1 (Gareau and Lima, 2010 OR). The 4 paralogs of SUMO share homology 
in certain regions and are different in few regions in its amino acid sequence (Figure 3-
1). Hence, they appear to alter both common and different substrates. For example, 
some substrates can be modified by both SUMO-1 and SUMO-2/3, while other 
substrates can only be modified by either of the SUMO paralog. To date, not much is 
yet known about the SUMO-4 paralog.  
	
Figure 3-1. Alignment of amino acid sequences of ubiquitin, SUMO1, SUMO2, 
SUMO3, and SUMO4. Shaded areas indicate similarities, and bolded sequence 
represent identical sequences. The consensus motif for SUMOylation is outlined in 
yellow, and the SUMO acceptor, lysine, is outlined in red. Both were absent in SUMO1, 
suggesting the inability of poly-SUMOylation on SUMO-1. The bold red line after 
glycine-glycine at residue 98 for all 5 proteins indicated the cleavage site of the C-
terminus tail to result in mature proteins. (Bohren et al, 2004) 
 
 SUMOs are conjugated to their target substrates via enzymatic machineries in a 
reversible process very similar to ubiquitylation (Figure 3-2). SUMO protein moiety is 
transcribed from its gene as an inactive precursor protein with a C-terminal extension 
(Wilson and Hochstrasser, 2016). A SUMO-specific protease, SENP, is then required to 
cleave the C-terminal extension of the precursor SUMO protein for its maturation, which 
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would expose two glycine residues required for conjugation (Li et al, 1999; 
Mukhopadhyay and Dasso, 2007). To initiate the SUMO conjugation process, E1 
SUMO-activating enzyme, a heterodimer of SAE1 and SAE2 subunits (Desterro et al, 
1999), transfers the AMP from ATP to adenylated SUMO (Hay, 2005). This AMP-SUMO 
bond is then broken and a thioester bond is formed with SAE2. Ubc9, a SUMO-specific 
conjugating enzyme, then transfers the thioester bond from the E1 enzyme to itself 
(Desterro et al, 1999). Unlike ubiquitin E2 conjugating enzymes, Ubc9 is able to directly 
distinguish substrate proteins for SUMOylation, and can catalyze formation of an 
isopeptide bond between SUMO and its target protein independent of an E3 ligase. The 
lysine residue that Ubc9 recognizes in the substrate protein is part of the SUMO 
consensus motif, ΨKxE, where Ψ indicates a large hydrophobic residue, x is any amino 
acid residue, and K lysine is the site of SUMO conjugation (Rodriguez et al, 2001). 
However, this consensus motif might not be found in every protein that can be modified 
by SUMO, suggesting the presence of some other sequence or a need for the E3 
ligase.  
 
 More importantly, SUMO-addition consensus motifs can also be found in the N-
terminus of SUMO-2/3 and SUMO-4, suggesting that these could be used for polymeric 
SUMO chains in these SUMO paralogs, but not in SUMO-1 (Tatham et al, 2001). Three 
SUMO paralogs, SUMO-1, SUMO-2 and SUMO-3, were later observed to form 
polymerization chains in vitro but its functional significance was not identified (Pichler et 
al, 2002). In vivo evidence of the SUMO polymerization was later observed by mass 
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spectrometry (Matic et al, 2008), and can occur via the lysine residue in the consensus 
motif in vivo and in vitro (Skilton et al, 2009), or via a lysine residue not in the 
consensus site in vitro (Wilson and Heaton, 2008).  
 
 
Figure 3-2. SUMO conjugation pathway. SUMO is transcribed as a precursor protein 
with an extended C-terminal peptide. SENP, a SUMO-specific protease, would cleave it 
to produce a mature SUMO protein. E1 ligase, a heterodimer, would then bind to SUMO 
for its transfer to the SUMO E2 conjugating enzyme, Ubc9. SUMO is then conjugated to 
its substrate from Ubc9 by the SUMO E3 ligase. For deconjugation from its substrate 
protein, SENP enzyme can cleave the bond between SUMO and its protein. The 
conjugation and deconjugation of SUMO is a rapid and dynamic process. 
 
  
3.1.2 Role of SUMO in epigenetic transcription regulation 
 SUMO was first identified in mammalian cells to function in repression of 
transcription modifying H4 in an E3-independent manner (Shilo and Eisenman, 2003). 
Similarly, all 4 histone proteins in S. cerevisiae can also be SUMOylated in vivo and 
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function to repress transcriptional activity (Nathan et al, 2006). There are different ways 
SUMOylation of histones could function as a repressor for transcription. One way would 
be the recruitment of other proteins, such as histone deacetylase HDAC1 and 
heterochromatin protein 1 (HP1), to the DNA. This would repress transcription and 
maintain silenced regions in the chromatin structure (Shilo and Eisenman, 2003). 
Another way would be to compete with activating histone modifications, such as 
acetylation, for sites of modification on histones. This was observed in S. cerevisiae 
when there was an inverse correlation between histone H2B acetylation and H2B 
SUMOylation at the GAL1 locus (Nathan et al, 2006). In contrast to this finding, histone 
H3 SUMOylation on a nearby lysine residue could be stimulated by histone acetylation 
in mammalian cancer cell line, HeLa (Hendriks et al, 2014). Hence, mammalian histone 
H3 could simultaneously be modified by both acetyl and SUMO on nearby lysine 
residues. When these cells were treated with a HDAC inhibitor, increased levels of 
histone H3 SUMOylation was observed. However, these levels decreased when cells 
were treated with a histone acetyltransferase inhibitor. The function of this novel cross-
talk between the 2 histone PTMs have yet to be determined, but suggests the 
complexity of SUMOylation in modifying histones for epigenetic regulation of 
transcription. 
 
 In addition to recruiting proteins or competing with other PTMs to regulate gene 
transcription levels, histone SUMOylation on H4 was found to modulate chromatin 
structure and long-range chromatin interactions (Dhall et al, 2014). The N-terminal tail of 
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H4 plays a role in chromatin condensation (Dorigo et al, 2003). By conjugating SUMO to 
its N-terminal tail, it could lead to other modifications in chromatin structure. In S. 
cerevisiae, all 4 core histone proteins and H2A-family variant, H2A.Z, have been 
detected in their SUMO-modified forms (Nathan et al, 2006; Kalocsay et al, 2009). In 
mammalian cells however, only H3 and H4 have been confirmed to be sumoylated 
(Hendriks et al, 2014). More importantly, histone SUMOylation have been identified in a 
myriad of organisms such as plants (Miller et al, 2010) and protozoan parasites (Issar et 
al, 2008). Its presence across species suggests histone SUMOylation as an 
evolutionarily conserved and significant chromatin PTM that adds complexity to gene 
regulation via epigenetics. Understanding the mechanisms and interplay of 
SUMOylation could allow us to potentially manipulate it as therapeutic targets in 
diseases resulting from un-regulated changes in gene transcription.   
 
3.1.3 Dichotomous role of SUMOylation in transcription regulation 
 Instead of directly attaching SUMO to histones for induction of PTMs, there are 
other ways SUMO can impact transcription. Most of the SUMO target proteins are 
involved in nuclear function, especially in transcription regulation (Seeler and Dejean, 
2003). SUMO can be conjugated to chromatin-modifying enzymes or proteins involved 
in transcription activation or repression to modify their functions and stability. SUMO-1 
conjugation to HDAC4 was observed to promote its deacetylation activity and serve to 
repress gene transcription levels (Kirsh et al, 2002). Overexpression of SUMO or Ubc9 
to hyper-SUMOylate specific gene promoters primarily repressed genes (Chupreta et al, 
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2005; Shiio and Eisenman, 2003) while knocking-down SUMOylation in cells resulted in 
gene expression activation (Spektor et al, 2011). One of the most common classes of 
proteins modified by SUMO includes transcription factors and co-regulators. Aside from 
mediating repression of transcription, SUMO can also enhance transcriptional activity by 
modifying certain transcription factors, such as Ikaros (Gómez-del Arco et al, 2005). In 
yeast studies, SUMO-modified proteins were found at promoters of constitutively active 
genes and Ubc9 and SUMO at promoters of inducible genes upon induction of gene 
activation (Rosonina et al, 2010). 
 
 Unlike the acetylation of histones that generally lead to increase in gene 
transcription by allowing easier access of the promoter region, SUMOylation of histones 
does not result in a direct black-and-white effect, and can lead to either activation or 
repression of transcription. Most of the current studies and research point to the fact 
that SUMOylation of a transcription factor results in recruitment of histone deacetylases, 
leading ultimately to the repression of gene transcription and expression (Yang and 
Sharrocks, 2004; Lindberg et al, 2010; Murata et al, 2010). However, there are some 
findings to suggest SUMOylation could enhance certain gene transcription, or even its 
activation (Guo and Sharrocks, 2009; Lyst et al, 2006). SUMO enrichment at active 
promoters was observed in S. cerevisiae and human fibroblasts (Neyret-Kahn et al, 
2013; Rosonina et al, 2010; Liu et al, 2015;). The dichotomous role of SUMOylation on 
transcription, partly due to its extensive impacts on chromatin structure and 
modifications, was exemplified with studies on Sp3, a transcription factor modified by 
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SUMO-1. Impeding SUMOylation of Sp3 resulted in differential effects on Sp3-target 
promoters to modify the structure of chromatin on multiple levels such as reducing 
levels of DNA and histone methylation, histone methyltransferases, HP1, and two ATP-
dependent chromatin remodelers (Ross et al, 2002; Stielow et al, 2010, 2008a, 2008b). 
These findings point to the fact that SUMOylation is not a simple switch to just silence or 
activate genes, but contributes to an important role in regulation gene transcription.   
 
3.1.4 SUMO and diseases 
 SUMOylation has been found to influence certain proteins involved in different 
diseases and in cellular processes characteristic to cancer, such as cell proliferation 
and apoptosis. Interestingly, SUMO was recently found to contribute to Alzheimer’s 
disease, which is a progressive neurodegenerative disease characterized by an 
accumulation of amyloid beta plaques and neurofibrillary tangles containing tau protein 
associated with microtubules. The amyloid precursor protein and the tau protein was 
found to be SUMOylated for its regulation, and findings suggest its involvement in the 
pathogenic pathway of Alzheimer’s diseases (Hoppe et al, 2015). Hence, by 
understanding more of its contribution to the pathway, SUMO could be used as a 
neuroprotectant to potentially treat Alzheimer’s disease. Additionally, SUMO is also 
implicated in modifying transcription factors essential for normal cardiac development, 
and deregulation of the baseline SUMOylation could result in cardiac diseases (Wang, 
2012). These studies suggest a role of SUMOylation in disease development. By 
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understanding the exact mechanistic pathway of SUMO, it can potentially be used as a 
therapeutic target for diseases. 
 
 Cancer is a type of disease that can target most of the body’s organs and impact 
people the most. In addition to being involved in meiosis and mitosis, genome-wide 
RNA interference screens scored several SUMO pathway components as genes 
required for cell proliferation (Schlabach et al, 2008). Loss of SUMO in human cancer 
cells resulted in decreased cell growth in vitro, with multinucleated cells going into 
senescence, and increased apoptosis (He et al, 2015). Furthermore, from the same 
study, in vivo xenograft tumor model showed significantly impaired tumor growth. This 
suggested the importance of SUMO pathway in cancer cell proliferation in vitro and in 
vivo, implying the use of SUMO pathways as a potential target for cancer therapies. 
However, more research is required to ensure the specificity of SUMO in cancer tumor 
cells as SUMO impacts pathways for regular cellular processes.  
 
3.1.5 Research rationale and objective 
 SUMOylation on histones generally suggests a role in repressing gene 
expression, but data have shown SUMOylation of some transcription factors can also 
function in  gene activation. Studies in yeast found that H2A.Z is SUMOylated at K126 
and K133 of the C-terminal tail of this variant in response to DNA double-strand breaks 
and DNA repair (Kalocsay et al, 2009). Taking these studies into consideration, we want 
to determine if H2A.Z, which is also involved in both gene repression and activation, 
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could be SUMOylated in mammalian cells. Secondarily, we want to take advantage of 
the proximity of H2A.Z to the nucleosome-free region (NFR) to identify potential 
SUMOylated targets (non-histone targets) recruited to the TSS. Our lab previously 
successfully utilized and described a technique termed BICON, which stands for 
Biotinylation-assisted Isolation of CO-modified Nucleosomes. We wanted to determine if 
we could use a modified version of this technique to isolate for biotinylated proteins that 
were modified by SUMO in proximity of H2A.Z. To do so, we fused the BirA ligase to 
H2A.Z and added the BirA substrate target, Avi-tag, to SUMO. Flag-NLS-BirA was used 
as a negative control to ensure the biotinylated bands observed were specific for H2A.Z 
instead of by random chance of BirA being in the nucleus, and the Flag-tag in H2A.Z-
Flag-BirA was used for detecting the expression of the protein by Flag antibody. Once 
we observe biotinylated SUMOylated proteins in context of H2A.Z proximity, we could 
conduct mass spectrometry analysis to identify putative transcription-related proteins 
that are SUMOylated. However, we cannot assume that all biotinylated proteins are at 
the TSS as H2A.Z is not exclusively localized to the TSS and could also be found in 
other regions of the genome. 
	 70	
3.2 Materials and Methods 
3.2.1 Cell culture, transfection, and plasmids 
 293T and HeLa cells were grown in Dulbecco’s Modified Eagle’s Medium 
(DMEM) High-Glucose with 10% fetal bovine serum (FBS) in 37℃ incubators with 5% 
CO2. Cells were passaged every 3-4 days when the cells were at 80-90% confluency. 
Plasmids were then transfected using PolyJet by the manufacturer’s protocol 
instructions. In co-transfection experiments, the ratio of H2A.Z-Flag-BirA/H2A.Z2-Flag-
BirA/Flag-NLS-BirA/H2A.X-Flag-BirA to Avi-SUMO1/Avi-SUMO3/Avi-Ub were 1:1. 
Because H2A.Z2 histone variant isoform was only discovered relatively recently, 
H2A.Z1 has generally been referred to as H2A.Z. With that said, H2A.Z would be 
interchangeably used with H2A.Z1. Cells were then harvested 48-hours post-
transfection and washed 2 times in Phosphate Buffered Saline (PBS) before 
centrifuging them down as cell pellets.  
 
3.2.2 Western blot analysis 
 Whole cell protein extraction was first conducted by trypsinization to lift adhesive 
cells off the culturing plate and collected as cell pellets. The cell pellets were washed 
with PBS once and lysed with boiling hot 2x SB before sonication at 40% duty cycle and 
30% output control for 13 pulses. The samples were then boiled for an additional 5 
minutes and spun down before transferring the supernatant to a new microcentrifuge 
tube. The protein samples from whole cell fraction were stored at -20℃ for analyses in 
the future.  
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 Proteins in the nuclear fraction was isolated by lysing the cell pellet with 0.2% 
Triton-X100 in Buffer A for 5 minutes on ice and centrifuged at 1300 G for 5 minutes at 
4℃. The supernatant containing cytoplasmic fraction was removed and the pellet 
containing the nuclear fraction was lysed in boiling hot 2x Sample Buffer or RIPA buffer 
before sonication at 40% duty cycle and 30% output control for 13 pulses or 95% output 
control 8 cycles at 8 pulses each. The nuclear fraction protein samples were either 
stored at -20℃ for Western blots or used immediately in immunoprecipitation. 
 
 Equal concentrations of proteins per sample, along with DTT, bromophenol blue, 
and additional 2X SDS buffer were boiled for 5 minutes before samples were resolved 
on 10% or 15% tris-glycine gels by SDS-PAGE. Gels were stained in Coomassie 
Brilliant Blue dye for an hour at room temperature before being de-stained in destaining 
solution overnight at room temperature on a nutator. Gels containing the IP-ed samples 
not observed by Coomassie Brilliant Blue dye were then stained with Silver stain (Pierce 
kit #). Samples for Western blot analysis were wet transferred from the gels to PVDF 
membrane by wet transfer method at 100V for 1 hour. 
 
 PVDF membranes were blocked with 5% non-fat milk in 1X TBS-T (for anti-Flag 
mono-clonal or anti-SUMO1) or 4% BSA in 1X TBS-T (for Avi-HRP antibody) for an 
hour at room temperature on a nutator. The membranes were then washed 3 times for 5 
minutes each with 1X TBS-T and probed overnight at 4℃ with primary antibodies in 2% 
milk in TBS-T at the respective dilutions; M2 Flag (1:15000), anti-SUMO1 (1:200), Avi-
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HRP (1:80 000). M2 Flag antibody was used to detect for expression of the 
constructs/plasmids while Avi-HRP was used to detect biotinylated proteins. SUMO1 
antibody was used to detect SUMOylated proteins. Membranes were then washed in 
TBS-T 3 times for 5 minutes and incubated in ThermoScientific Supersignal West Pico 
Chemiluminescent Substrate or the higher sensitivity Millipore Immobilon Western 
Chemiluminescent HRP Substrate for 5 minutes. They were then exposed to 
autoradiography film and developed in a dark room accordingly.  
 
3.2.3 Heat shock and DNA damage treatments 
 Heat shock was conducted at 42℃ for 1 hour and DNA damage was induced 
with 200 ng/uL of methyl methanesulfonate (MMS) for 3 hours at 37℃. Both treatments 
were respectively given to 293T cells and HeLa cells 48 hours post-transfection, and 
nuclear fraction protein were then obtained with Buffer A + 0.2% Triton-X100 and 2x SB. 
 
3.2.4 Transcription inhibition with Flavopiridol and Triptolide drugs 
 Transfected 293T cells were treated with 1 uM of Flavopiridol resuspended in 
water and 1 uM of Triptolide resuspended in DMSO for 24 hours and proteins in the 
nuclear fraction were obtained with Buffer A + 0.2% Triton-X100 and 2x SB. 
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3.2.5 Immunoprecipitation of biotinylated SUMOylated proteins with Streptavidin 
sepharose beads 
 Nuclear fraction proteins from 2 15-cm cell culture dishes were diluted in equal 
volume of Buffer D with 2x protease inhibitors for proteins lysed with 2x Sample Buffer 
or RIPA buffer with 2x protease inhibitors for proteins lysed with RIPA buffer. 
Streptavidin sepharose beads were washed 3x in either Buffer D or RIPA buffer, 
depending on the lysis buffer, and centrifuged at 7000 G for 30 seconds. Nuclear 
fraction proteins were then incubated with 50 uL Streptavidin sepharose beads on a 
nutator at 4℃ overnight, and washed 3x each in RIPA buffer with protease inhibitors 
and 50 mM ammonium bicarbonate with protease inhibitors. Biotinylated proteins bound 
to the streptavidin beads were then eluted with 2x sample buffer and boiled for 5 
minutes. Samples were then stored at -20℃. 
 
3.3.6 Sample preparation for mass spectrometry  
 Samples to be sent for mass spectrometry (MS) were all prepared in a laminar 
flow hood for most steps possible to prevent or minimize keratin contamination in the 
samples. Lysis buffers and wash buffers were also freshly prepared in the laminar flow 
hood before the start of the pulldown. There were 2 different ways the samples were 
prepared for MS; 1) on-bead trypsinization of samples; and 2) in-gel tryptic digest of 
samples. Nuclear proteins were extracted from transfected cells with Buffer A + 0.2% 
Triton-X100 and 2x SB or with RIPA and IP-ed with Streptavidin beads. 
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3.2.6.1 On-bead trypsinization of samples  
 Instead of eluting biotinylated proteins bound on the Streptavidin beads with 2x 
Sample Buffer and boiling it, the beads were incubated with 1 ug of Trypsin Gold 
overnight at 37℃ on a nutator and an additional 1 ug was added the next day and 
incubated further for 2 hours. Supernatant was later collected and transferred to a clean 
microcentrifuge tube, and beads were rinsed twice with Molecular Grade water. The 
rinses were combined with original supernatant and centrifuged at high speed for 10 
minutes before transferring most of the supernatant to a clean microcentrifuge tube to 
prevent contamination of beads. The samples were then lyophilized in a speed-vac and 
resuspended in 5% formic acid. They were stored at -80℃ until ready for mass 
spectrometry analysis. 
 
3.2.6.2 In-gel tryptic digest of samples 
 Biotinylated samples were incubated with Streptavidin sepharose beads 
overnight at 4℃ and eluted as normal in 2x SB. The elute samples were run on a pre-
cast 10% tris-glycine gel and SDS-PAGE was conducted at 150V for 17 minutes and 
200V for 60 minutes. Specific protein spots were excised depending on their molecular 
weight ranges with a sterile blade using a Silver stained gel as guide and transferred 
into clean microcentrifuge tubes. The gel pieces were generously covered with HPLC-
grade acetonitrile and incubated for 10-20 minutes, when the gel would shrink. The gel 
pieces were then washed with HPLC-grade water for 10-20 minutes for it to re-swell. 
This shrinking and swelling was conducted 2 additional times before the gel pieces were 
	 75	
dried in a speed-vac. The dried gel pieces were then incubated in 10 mM DTT in 100 
mM ammonium bicarbonate for 60 minutes at 37℃. The solution was removed and the 
gel pieces were re-suspended in enough acetonitrile for 20 minutes to allow shrinkage. 
The solution was removed and 55 mM IAA in 100 mM ammonium bicarbonate was 
added for 15 minutes before drying the gel pieces with a speed-vac. The dried gel 
pieces were then incubated with enough 100 mM ammonium bicarbonate containing 1 
ug of Trypsin Gold and digested overnight at 37℃. The samples were centrifuged the 
next day for 5 minutes at 14000 RPM and supernatant was transferred to a new clean 
microcentrifuge tube to be set aside. Peptide from the gel pieces were then further 
extracted by incubating with enough 50% acetonitrile with 5% formic acid for 30 minutes 
and vortexed briefly every 10 minutes before centrifugation. The supernatant from this 
step was then combined with the initial supernatant. Extraction was repeated once more 
and supernatants were lyophilized with a speed-vac before storage in -80℃ until ready 
for mass spectrometry analysis.  
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3.3 Results 
3.3.1 H2A.Z is not SUMOylated in 293T cells  
 H2A.Z is known to be ubiquitylated in mammalian cells. We used H2A.Z 
ubiquitylation to test if we could use the Avi-tag BirA system to detect the known PTM of 
H2A.Z before using it to test for the SUMOylation of H2A.Z. To do so, BirA fused to 
H2A.Z-Flag and Avi-tag fused to ubiquitin were co-expressed in 293T cells. In parallel, 
we also co-transfected either H2A.Z-Flag-BirA or Flag-NLS-BirA with either Avi-SUMO1 
or Avi-SUMO3. SUMO2 homolog was not used as it has high amino acid sequence 
similarity to SUMO3, and so SUMO3 could be regarded as SUMO2/3. Whole cell 
extract proteins were then used in Western blot. Flag-antibody was used to detect for 
the expression levels of the transfected constructs and the potential SUMOylation of 
H2A.Z. H2A.Z-Flag-BirA runs at approximately 50 kDa on SDS gels, whereas its Avi-
ubiquitylated form runs at 59 kDa and the Avi-SUMOylated form runs at 63 kDa. 
Endogenous ubiquitin modified H2A.Z-Flag-BirA corresponds to a band at 58 kDa. Flag-
NLS-BirA runs at 35 kDa, and was used as a control to ensure that the bands observed 
with H2A.Z-Flag-BirA were specific for H2A.Z and not purely due to chance. Bands 
specific to H2A.Z would therefore not show up with Flag-NLS-BirA, and so, Flag-NLS-
BirA would interchangeably be referred to as a negative control. Expected band sizes 
are represented in Table 3-1 for future reference.  
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Table 3-1. Expected protein sizes of constructs transfected and modified H2A.Z-
Flag-BirA. Proteins under the “Unmodified” represents the expected molecular weight 
of the proteins that should be expressed from the transfected plasmids. “Modified 
H2A.Z-Flag-BirA” indicates the predicted molecular weight of H2A.Z-Flag-BirA modified 
by either Avi-ubiquitin, endogenous ubiquitin, or Avi-SUMO.  
 
  
Protein Expected molecular weight (kDa)
Unmodified
Flag-NLS-BirA 35
H2A.Z-Flag-BirA 50
Avi-Ubiquitin 9
Avi-SUMO 13
Modified H2A.Z-Flag-BirA
Av-ubiquitylated H2A.Z-Flag-
BirA 59
Ubiquitylated H2A.Z-Flag-BirA 58
Di-ubiquitylated H2A.Z-Flag-
BirA 66
Avi-SUMOylated H2A.Z-Flag-
BirA 63
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 H2A.Z Avi-Ubiquitylation was observed with a high intensity band at 59 kDa with 
the Avi-HRP blot (Figure 3-3, blue arrow). Although additional bands were observed  
after high exposure of the Avi-HRP blot, they were of extremely low intensity compared 
to the band at 59 kDa. The Flag blot also supported H2A.Z-Flag-BirA ubiquitylation 
when a similar band at 59 kDa was also picked up by the Flag-antibody (Figure 3-3, 
blue arrow). A band at 58 kDa was also observed with the Flag blot, corresponding to 
the endogenous ubiquitylated H2A.Z-Flag-BirA protein (Figure 3-3, red arrow). The 
detection of ubiquitylated H2A.Z by both Avi-HRP and Flag-antibody suggests the 
efficiency of the Avi-tag BirA and that we could reliably use the system to determine 
SUMOylation of H2A.Z. Doing so, a band at 63 kDa was detected with Avi-HRP blot and 
SUMO1 blot to indicate Avi-SUMOylated H2A.Z-Flag-BirA (Figure 3-3, red asterisk). We 
also observed multiple bands of equal intensity around 63 kDa and additional bands at 
other molecular weights in the Avi-HRP and SUMO-1 blots. Most importantly, compared 
to the intensity of the Avi-HRP-detected Avi-ubiquitylated H2A.Z-Flag-BirA band, it is 
clear that if there were any Avi-SUMOylation of H2A.Z-Flag-BirA, the levels were very 
low in comparison to the Avi-ubiquitylated form. Furthermore, a similar band at 63 kDa 
was observed with Flag-NLS-BirA control with Avi-HRP and SUMO1 antibody, 
indicating the non-dependency of that band on H2A.Z. To support the hypothesis that 
the 63 kDa band observed with H2A.Z-Flag-BirA is not the SUMOylated form, the Flag 
antibody was unable to pick up the band at 63 kDa. We hence conclude that although 
there is no clear SUMOylation of H2A.Z as no dominant band was observed at its 
expected size and the band that was detected was not specific to H2A.Z. However,  
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Figure 3-3. Preliminary test for biotinylation of SUMOylated proteins in proximity 
of H2A.Z. Flag blot ensured the expression of the plasmids transfected were roughly 
equal. Avi-Ubiquitin (Avi-Ub) was used as a positive control for biotinylation of H2A.Z 
and Flag-NLS-BirA was used as a control to ensure bands observed were specific to 
H2A.Z and not due to its presence in the nucleus. Blue arrows represent Avi-
ubiquitylated H2A.Z-Flag-BirA, and the red arrow indicates endogenous ubiquitylated 
H2A.Z-Flag-BirA. Red asterisks show the 63 kDa band that could correspond to Avi-
SUMOylated H2A.Z-Flag-BirA.  
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there might be low levels of H2A.Z SUMOylation and the presence of multiple bands 
with H2A.Z-Flag-BirA suggests potential H2A.Z-dependent Avi-SUMOylation of other 
target proteins. We can then use the Avi-tag BirA system with H2A.Z to also identify 
some target proteins of SUMO at the TSS. Moving forward, we decided to focus on 
SUMO1 as more biotinylated bands were observed in Avi-HRP blot compared to 
SUMO3.  
 H2A.Z-Flag-BirA or Flag-NLS-BirA was again co-expressed with Avi-SUMO1 in 
293T cells. Whole cell extract and nuclear extract were prepared as an optimization 
step to determine which protein fractionation method would allow for clearer detection of 
biotinylated bands. The data showed that there were more distinct bands with the 
nuclear extracts when blotted with Avi-HRP and SUMO1 antibody (Figure 3-4A). 
Therefore, we consistently harvested nuclear extracts for our analyses in subsequent 
experiments. For higher molecular weight proteins, we decided to run the samples in 
lower percentage polyacrylamide gels for better resolution. We observed the 63 kDa 
band corresponding to Avi-SUMOylated-H2A.Z-Flag-BirA in Avi-HRP, SUMO1, and 
Flag blots (Figure 3-4B blue arrows). However, we cannot be certain of this since the 
same size band was also seen in the Flag-NLS-BirA control in Avi-HRP blot, and the 
intensity of the 63 kDa band in H2A.Z-Flag-BirA sample is very low compared to other 
bands detected in SUMO1 and Flag blots. This supports our statement that H2A.Z is 
either lowly SUMOylated, or not modified by SUMO at steady states in 293T cells.  
 Additional bands were again observed in H2A.Z-Flag-BirA samples that were 
absent with Flag-NLS-BirA, suggesting potential SUMO targets dependent on H2A.Z.    
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Figure 3-4. Biotinylation of potential transcription start site proteins modified by 
Avi-SUMO1 near proximity of H2A.Z histone variant tagged with BirA ligase. (A) 
Western blot analysis conducted on nuclear and whole cell extract from 293T cells 
transfected with Avi-SUMO1 and Flag-NLS-BirA or H2A.Z-Flag-BirA. (B) A biological 
repeat was conducted and the nuclear fraction proteins were then extracted and used in 
Western blot for analysis with Avi-HRP, SUMO1 antibody, Flag antibody and AM H2A.Z 
antibody. The 63 kDa band that could potentially be Avi-SUMOylated-H2A.Z-Flag-BirA 
is highlighted in blue arrows while H2A.Z-Flag-BirA-dependent-Avi-SUMOylated targets 
are shown in red asterisks. 
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A few bands at different molecular weights were observed in the H2A.Z-Flag-BirA-
expressing sample and absent in the Flag-NLS-BirA control; a band at 45 kDa, bands 
above the 63 kDa mark, a band at 110 kDa (Figure 3-4B, red asterisks) This suggested 
that they might be SUMOylated proteins that were biotinylated due to its proximity to 
H2A.Z-BirA. These bands are consistently observed throughout the rest of the 
experiments described in this project, raising the confidence that they are putative 
H2A.Z-Flag-BirA-SUMOylated targets.  
 
3.3.2 H2A.Z is not SUMOylated in response to heat shock or DNA damage 
 Previous studies have shown that heat shock treatment can induce transcription 
of some target genes and lead to SUMOylation of some transcription factors. We 
wanted to test if H2A.Z was SUMOylated in response to heat shock, and whether any of 
the biotinylated and Avi-SUMOylated proteins detected in our system were related to 
the heat shock response. If H2A.Z SUMOylation be involved in response to heat shock, 
a high intensity band at 63 kDa would be observed with Avi-HRP, SUMO1 antibody and 
Flag antibody after heat shock is conducted. If SUMO targets proteins that are involved 
in heat shock response, more biotinylated bands would be observed. Heat shock 
treatment was conducted on transfected 293T cells for one hour at 42℃. We did not 
observe the expected results, and no additional bands were observed after heat shock 
(Figure 3-5), suggesting that heat shock does not induce SUMOylation of H2A.Z or 
H2A.Z dependent target proteins.  
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Figure 3-5. No changes in state of H2A.Z SUMOylation in response to heat shock 
treatment.  293T cells were transfected with Avi-SUMO1 and either H2A.Z-BirA or 
Flag-NLS-BirA in duplicate. One set was then incubated in 42℃ for an hour while the 
other was in normal 37℃ incubator. Nuclear fraction were then extracted and used in 
Western blot for analysis with Avi-HRP, SUMO1 antibody, Flag antibody and AM H2A.Z 
antibody. No additional biotinylated bands were observed with the heat shock treatment. 
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H2A.Z SUMOylation was originally detected in yeast under DNA damage. To test 
whether this pathway was conserved in mammalian cells, DNA damage was induced in 
the transfected 293T cells using MMS treatment for 3 hours. For comparison, we also 
performed the same experiment using HeLa cells as well since that cell line has been 
more commonly used for DNA-damage studies. In addition, another isoform of the 
histone variant, H2A.Z2-Flag-BirA, was also co-transfected along with Avi-SUMO1 since 
a recent paper (Fukuto et al, 2018) claimed that this specific isoform of H2A.Z was 
SUMOylated in a DNA damage-dependent manner. Gamma H2A.X (#H2A.X) was used 
as an indicator of DNA damage. Higher #H2A.X levels were observed in samples 
treated with MMS in comparison to samples without MMS treatment (Figure 3-6A). The 
increase in #H2A.X levels were more evident in 293T cells than HeLa cells, indicating a 
more efficient DNA damage induction in 293T cells. After assuring induction of DNA 
damage in the cells, we went on to determine if doing so would result in SUMOylation of 
H2A.Z1 or H2A.Z2 in response. However, we did not see any a band of higher intensity 
at 63 kDa after DNA damage in both H2A.Z1 (Figure 3-6B) and H2A.Z2 (Figure 3-6C) in 
either of the cell lines. This suggests that neither H2A.Z1 nor H2A.Z2 SUMOylation is 
involved in DNA damage response.  
 
3.3.3 Putative H2A.Z-Flag-BirA-SUMOylated targets are not dependent on on-going 
transcription 
 We wanted to further characterize the biotinylated (presumably SUMOylated) 
bands corresponding to potential putative H2A.Z-Flag-BirA-SUMOylated targets.  
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Figure 3-6. SUMOylation is not involved in DNA damage response of H2A.Z1 or 
H2A.Z2 in 293T and HeLa cells. DNA damage was induced to 293T cells 48-hours 
post-transfection by MMS for 3 hours at 37℃. (A) Gamma H2A.X detection was used to 
ensure DNA damage induction. In 293T cells, a more intense band was observed in the 
presence of MMS. This increase in intensity with MMS treatment was not very distinct in 
HeLa cells. Flag antibody was used as a control to ensure equal expression and loading 
of the plasmids transfected. (B) DNA damage was conducted as described to 293T and 
HeLa cells transfected with Avi-SUMO1 and H2A.Z1-BirA or Flag-NLS-BirA. Nuclear 
fraction proteins were analyzed with Western blot. C) DNA damage was conducted as 
described to 293T and HeLa cells transfected with Avi-SUMO1 and H2A.Z2-BirA or 
Flag-NLS-BirA. Nuclear fraction proteins were analyzed with Western blot.   
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SUMOylation seem to be related to activation of transcription, so we hypothesized that 
these SUMOylated proteins detected by H2A.Z are related to ongoing transcription. 
Transfected 293T cells were treated with two transcription inhibitors, Flavopiridol and 
Triptolife, for 24 hours before nuclear extract was prepared. There did not seem to be 
any distinct changes in the intensity nor the number of biotinylated SUMOylated bands 
with Flavopiridol (Figure 3-7A) as the same pattern of bands were observed after 
treatment. Similar observations were made with Triptolide treatment, as no changes in 
the pattern of biotinylated bands were observed (Figure 3-7B). This supports our 
conclusion that inhibition of transcription in 293T cells does not affect the H2A.Z-Flag-
BirA-dependent biotinylated bands. Hence, our hypothesis that the biotinylated 
(presumably SUMOylated) proteins detected by H2A.Z are related to ongoing 
transcription. 
 
3.3.4 Purification of the putative H2A.Z-Flag-BirA-SUMOylated targets 
 We’ve consistently observed bands representing biotinylated proteins dependent 
on H2A.Z-Flag-BirA in our nuclear extracts that were detected by the Avi-HRP blot. To 
confirm the modification by H2A.Z-BirA on Avi-SUMO1 targets, Streptavidin beads were 
used to pull down and purify the biotinylated proteins from the nuclear extracts of 
transfected cells. Streptavidin beads bound with the protein samples were washed with 
increasing stringency (0.2% Triton-X100 and 0.5% Triton-X100 in buffer A) to ensure 
proteins bound to the beads were specific. The biotinylated proteins were then eluded  
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A.             B. 
 
Figure 3-7. Biotinylated proteins modified by Avi-SUMO1 potentially at the 
transcription start site are largely not dependent on transcription. 293T cells were 
transfected with Avi-SUMO1 and H2A.Z-BirA or Flag-NLS-BirA, and nuclear fraction 
proteins were extracted for analysis with Western blot. Before protein extraction and 24-
hours post-transfection, the cells were treated to either Flavopiridol (A) or Triptolide (B) 
for 24 hours to inhibit transcription. DMSO and water were used as the negative 
controls for the respective treatments. M2 Flag detected bands appropriately at 35 kDa, 
representing Flag-NLS-BirA, and at 50 kDa and 59 kDa, representing H2A.Z-Flag-BirA 
and ubiquitylated H2A.Z-Flag-BirA.  
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from the beads with 2x SB and analyzed with Western blot. The H2A.Z-Flag-BirA-
dependent biotinylated bands at 45 kDa, around 63 kDa, and around 100 kDa were  
observed to be enriched in the eluate fraction (Figure 3-8, red asterisks). This signified 
that the proteins detected by Avi-HRP blotting of the total nuclear extracts were also 
captured by the Streptavidin beads, and that these bands do correspond with 
biotinylation. 
 
 Streptavidin immunoprecipitation was conducted again, but with increased 
washing stringencies to ensure that the proteins bound to the Streptavidin beads were 
indeed biotinylated. In addition, we also tried another method of extracting nuclear 
proteins by using RIPA and compared it to nuclear proteins extracted with 2x SB to 
ensure the reproducibility of the H2A.Z-Flag-BirA-dependent biotinylated bands. The 
input and eluate fractions were then analyzed in Western blot. H2A.Z-Flag-BirA-
dependent biotinylated bands were still observed with the Avi-HRP blot and SUMO1 
blot (Figure 3-9, red asterisks). However, SUMO1 antibody was consistently unable to 
detect the 45 kDa band, which might suggest that the corresponding protein might not 
be Avi-SUMOylated. Biotinylation cannot occur on proteins that do not contain the Avi-
tag, and so SUMO1 antibody being unable to pick up the 45 kDa band might be due to 
Avi-tag or any modification on the protein itself occluding the recognition site of the 
antibody.  
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Figure 3-8. Pull-down of biotinylated proteins using Streptavidin sepharose beads. 
293T cells were transfected with Avi-SUMO1 and either H2A.Z-BirA or Flag-NLS-BirA. 
Nuclear fraction was extracted with Buffer A + 0.2% Triton-X100 and 2x SB before 
diluting in Buffer D +PI for immunoprecipitation with Streptavidin sepharose beads. The 
unique bands observed with H2A.Z-BirA but absent in the negative control was enriched 
after IP but there were still bands observed in the negative control as well indicating 
non-specific binding of proteins to the beads. H2A.Z-Flag-BirA-dependent-Avi-
SUMOylated targets are shown in red asterisks.   
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Figure 3-9. Comparison of pull-down of biotinylated proteins using Streptavidin 
sepharose beads with different nuclear lysing buffer and use of more stringent 
bead washing steps. 293T cells were transfected with H2A.Z-Flag or Flag-BirA with 
Avi-SUMO1 and nuclear fraction proteins were obtained 48-hours post-transfection with 
either RIPA buffer or 2x SB as indicated. Biotinylated proteins were then pulled-down 
with Streptavidin sepharose beads and washed more stringently with RIPA buffer +PI 
and 50 uM ammonium bicarbonate 3x each. Nuclear fraction with RIPA buffer seemed 
to be cleaner but the unique bands were more distinct when lysed with 2xSB. H2A.Z-
Flag-BirA-dependent-Avi-SUMOylated targets are shown in red asterisks.   
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Altogether, our data support the H2A.Z-Flag-BirA-dependent biotinylated bands at 45 
kDa and several other higher molecular weight proteins to be proteins that are 
potentially SUMOylated and biotinylated. Therefore, it would be of interest to identify 
those SUMOylation targets and whether they are normally recruited to transcription start 
sites and hence in proximity to H2A.Z.  
 
3.3.5 Mass spectrometry identification of the putative H2A.Z-Flag-BirA-SUMOylated 
targets 
 The detection of the putative H2A.Z-Flag-BirA-SUMOylated proteins by Avi-HRP 
and also by Streptavidin beads pull down suggests that they are indeed biotinylated and 
SUMOylated. In order to prove that and determine the identity of the biotinylated bands 
corresponding to putative H2A.Z-Flag-BirA-SUMOylated targets, we hoped to use mass 
spectrometry (MS) as a tool for identification. The first round of samples sent for mass 
spectrometry (biochemical data not available) were from on-bead trypsinization of 
biotinylated proteins after nuclear extraction using 2x sample buffer. Analysis was 
conducted by Peter Liuni and are pending. 
 
 The second round of MS samples were more specific to the bands we wanted to 
identify, and in-gel trypsinization was used. RIPA buffer with optimized sonication was 
used instead to extract nuclear proteins and eluted with 2x SB before running on a pre-
cast Novex gel. Silver stain was conducted with the samples beforehand to ensure 
proteins were present and to visualize bands to be excised. Bands that were cut in-gel  
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Figure 3-10. Confirmation of pulled down biotinylated protein samples for mass 
spectrometry via silver stain and Western blots. 293T cells were transfected as per 
usual with H2A.Z1-BirA or Flag-BirA and Avi-SUMO1 and nuclear lysates were 
collected. Unlike the prior round of mass spectrometry, nuclear fraction was lysed RIPA 
buffer and sonication this time. Proteins bound the Streptavidin beads were eluted with 
2x SB and boiled for 5 minutes before running on a 10% gel. A small fraction of the 
elute samples were used for silver stain (A) to determine the band sizes to be excised 
for mass spectrometry and for Western blot analysis (B) to ensure the presence of the 
distinct band at approximately 45 kDa that was absent in the control (Flag-BirA) as well 
as a few other bands that seemed to be distinct in H2A.Z-BirA samples but not in the 
control. The red boxes shown in (A) represent the bands that were excised from the gel 
and sent for mass spectrometry analysis.  
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were highlighted in red on the silver stain (Figure 3-10A) and sent for MS analysis by 
Peter Liuni. Leftover samples were then used in Western blot analysis to confirm proper 
purification of biotinylated SUMOylated proteins, which was supported by presence of 
H2A.Z-Flag-BirA-dependent biotinylated proteins that run at 45 kDa, around 63 kDa, 
and around 100 kDa (Figure 3-10B).  
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3.4 Discussion 
 Studies have shown the importance of PTMs on influencing chromatin structure 
and function as well as regulating transcription. One such PTM involved in many 
nuclear functions is the covalent addition of the SUMO protein. Yeast studies have 
shown that H2A.Z is able to be modified by SUMO (Nathan et al, 2006; Kalocsay et al, 
2009) while in mammalian cells, only H3 and H4 core histones were previously known 
to be SUMOylated (Hendriks et al, 2015). To test if we see the same phenomena for 
H2A core histone variant H2A.Z in mammalian cells, we utilized the Avi-tag BirA system 
to biotinylate Avi-SUMOylated targets and purify the biotinylated proteins. H2A.Z was 
not observed to be a significant target of SUMO modifications in 293T cells and HeLa 
cells. Although we did observe a band at 63 kDa potentially corresponding to 
biotinylated Avi-SUMOylated-H2A.Z-Flag-BirA, the intensity of the band was extremely 
low compared to other present bands. In addition, the same band was observed in the 
Flag-NLS-BirA control, indicating that the 63 kDa protein is not specific to H2A.Z-BirA. 
Altogether, our data showed that H2A.Z is not SUMOylated in mammalian cells. The 
presence of multiple bands corresponding to biotinylated H2A.Z-Flag-BirA-dependent 
Avi-SUMOylated proteins suggests that we could also use the Avi-tag BirA system to 
detect and identify SUMOylated proteins in proximity to H2A.Z. The presence of these 
additional bands dependent on H2A.Z-Flag-BirA suggests that the BirA ligase on H2A.Z 
was able to reach out to the Avi-tag on other SUMOylated proteins in proximity to H2A.Z 
and attach biotin to those SUMOylated proteins. We hence took advantage of the 
localization of H2A.Z-containing nucleosomes at the regions flanking the NFR or TSS to 
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detect other SUMO targets that could potentially be proteins involved in transcription. 
We noticed a clear band at 45 kDa that would always appear distinctly with H2A.Z-Flag-
BirA but never in the negative control, suggesting the specificity of it to H2A.Z. In 
addition, there were additional bands above 63 kDa and around 100 kDa that were also 
present with H2A.Z-BirA and absent in the negative control. These multiple bands were 
consistently observed with Western blot, supporting the hypothesis that they are 
putative H2A.Z-Flag-BirA-dependent Avi-SUMOylated targets. Although H2A.Z mostly 
flanks the TSS, a caveat would be that all proteins biotinylated by H2A.Z-Flag-BirA 
cannot be assumed to be localized to the TSS or NFR as H2A.Z is not exclusively found 
at TSS.  
 
 Changes in SUMOylation states of specific proteins were observed in HeLa cells 
in response of heat shock (Golebiowski et al, 2009). We therefore conducted heat 
shock treatment to induce transcription of some target genes and determine if it would 
result in SUMOylation of H2A.Z or additional transcription factors. However, we were 
unable to detect any additional biotinylated-Avi-SUMOylated proteins after heat shock, 
suggesting that the H2A.Z was not modified by SUMO in response to heat shock. 
Putative H2A.Z-Flag-BirA-dependent Avi-SUMOylated targets were also not involved in 
heat shock response. Both SUMO and H2A.Z are individually known be involved in 
DNA damage repair responses (Hendriks & Vertegaal, 2015; Xu et al., 2012). Recently, 
a paper published their observations of H2A.Z2 histone variant isoform being 
SUMOylated in response to DNA damage in HeLa cells (Fukuto et al, 2018). To 
	 96	
determine if H2A.Z1 or H2A.Z2 is indeed SUMOylated in response to DNA damage in 
our hands, MMS treatment was conducted in both 293T and HeLa cell lines. We did not 
observe SUMOylation of H2A.Z2 in either cell lines. There were no modifications in the 
Western blot banding pattern before and after DNA damage for both H2A.Z1 and 
H2A.Z2 in both cell lines. This suggested that SUMOylation might not be involved in 
DNA damage in these cancer cell lines. However, the DNA damaging agent we used, 
MMS, is believed to stall replication forks to induce DNA damage (when it stalls 
replication forks, double-strand breaks can be formed) (Lundin et al, 2005), while 
SUMOylation of H2A.Z2 in response to DNA damage was observed through double-
stranded breaks using ionizing radiation (Fukuto et al, 2018). This could potentially 
explain why we do not see the involvement of SUMO in facilitating H2A.Z2 exchange in 
nucleosomes in response to DNA damage. 
 
 We wanted to determine if these putative biotinylated H2A.Z-Flag-BirA-
dependent Avi-SUMOylated proteins were dependent on on-going transcription, which 
would suggest their role in binding to the transcription start site and being SUMOylated 
for transcription. We used two transcription inhibitors, Flavopiridol and Triptolide, to 
ensure the results observed were consistent with each other. The distinct biotinylated 
SUMOylated bands observed in H2A.Z-Flag-BirA did not decrease with the inhibition of 
transcription. This suggests that the biotinylated SUMOylated proteins that were 
localized in proximity to H2A.Z might not contribute to on-going transcription. With that 
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said, these results are not conclusive as the successful occurrence of transcription 
inhibition by both drugs in 293T cells have yet to be validated due to time constraints. 
 
 To further ensure the distinct bands observed exclusively with H2A.Z-Flag-BirA 
were indeed biotinylated due to proteins modified by Avi-SUMO, Streptavidin beads 
were used to purify for biotinylated proteins as biotin has a strong affinity to Streptavidin. 
The detection of the bands at around 45 kDa, above 63 kDa, and 100 kDa with Avi-HRP 
after Streptavidin IP suggested they were indeed biotinylated and potentially 
SUMOylated, as BirA would only be able to biotinylate Avi-tag, which is fused to 
SUMO1. Furthermore, the faint band at 63 kDa corresponding to potential Avi-
SUMOylated H2A.Z-Flag-BirA was no longer observed with Flag antibody after 
Streptavidin IP, indicating that H2A.Z is not SUMOylated in mammalian cells, or at least 
in 293T cells. This supported the postulation that the band at around 63 kDa observed 
with Flag antibody might have been the di-ubiquitylated form of H2A.Z-BirA. We then 
hoped to identify the putative H2A.Z-Flag-BirA-dependent Avi-SUMOylated targets 
we’ve consistently observed with Western blots and Streptavidin IPs with mass 
spectrometry (MS). We excised specific bands at the molecular weights previously 
mentioned to test whether MS could detect peptides corresponding to SUMO C-
terminus joined to the target protein via isopeptide linkage. However, due to time 
constraints as well as equipment malfunction, we are unable to present any additional 
information about the identity of SUMOylated proteins in proximity to H2A.Z.  
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3.4.1 Future directions and implications 
 Going forward, we should also confirm with RT-qPCR that the transcription 
inhibition with Flavopiridol and Triptolide had indeed worked. This would provide support 
that the results we observed was actually due to the inhibition of transcription. The 
experiment can then be repeated to show that the data we observed is consistent and 
not due to chance. Additionally, we should also repeat the DNA damage experiment by 
inducing double-stranded breaks instead of stalling replication forks. One way we could 
achieve it is by using CRISPR-Cas9 with the guide RNA targeting Alu elements. As 
there are many Alu elements in the human chromosome, Cas9 would be able to induce 
double-stranded breaks at many sites, causing DNA damage. We could then mimic the 
conditions that Fukuto lab utilized to observe H2A.Z2 exchange facilitated by SUMO in 
response to DNA damage and determine if we could see the same effect in our hands. 
We could use more than one cell line, such as with 293T and HeLa cells, to ensure that 
SUMO facilitation of H2A.Z2 exchange in response to DNA damage is universal.  
 
 Once we’ve obtained data from the MS and analyzed them, we would be able to 
identify the SUMOylated proteins that were localized in proximity to H2A.Z. Additional 
biological and technical repeats for mass spectrometry could be conducted to ensure 
the results are reliable and accurate. Once the identities of these proteins are verified, 
we could learn more about the SUMO targets and the regulatory pathways they 
contribute to. In doing so, we would be able to understand the mechanistic role of 
SUMO in certain diseases and develop targeted therapeutics with less side effects. 
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